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The PhD thesis addresses the analysis of GABA and glycine cotransmitting (GgC) 
neurons in the Pre-Bötzinger Complex (PBC), a region important for rhythm generation 
of the respiration. GgC neurons were identified in the PBC using different approaches 
including single-cell RT-PCR and immunohistochemistry. Furthermore, novel transgenic 
mouse-lines were generated to facilitate the analysis of these neurons in-vivo and in 
living-tissue preparations: The mouse-line Cofluor allows the identification of GABAergic, 
glycinergic as well as GgC neurons by the expression of different fluorescent proteins. 
This mouse-line was used to investigate the number of cells of each neuron type during 
development from E15.5 to 2.5 month revealing a decrease of GgC neurons paralleled 
by an increase of glycinergic and GABAergic neurons. The mouse line COTRIND 
expresses the tamoxifen-inducible Split-CreERT2 system exclusively in GgC neurons 
allowing for the permanent labelling of these neurons with the Red Fluorescent Protein at 
the time-point of tamoxifen application. In COTRIND mice, GgC neurons were 
irreversibly labelled at the age of P1/P2 and analysed at the age of three days as well as 
after 2.5 month to investigate their fate by using immunohistochemistry. It was found that 
GgC neurons differentiated to mostly glycinergic neurons and to a minor percentage to 
GABAergic neurons whereas some GgC neurons remained GgC neurons. The results 
obtained from this study disclosed the presence of GgC neurons in the PBC of mice and 
their development from the embryonic day 15.5 to the adult stage. Furthermore, the 
inducible Split-CreERT2 system was for the first time established in transgenic 
COTRIND mice and found to be functional in vivo without leakage. With the novel 
transgenic mouse lines the present work provides tools for the analysis of GgC neurons 
in the PBC and contributes to the characterisation of this neuron type including the role 
for rhythm generation of the respiration.     
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1. Introduction 
1.1 Phenomenon Cotransmission  
A longstanding dogma in neurobiology is the “one-neuron-one-transmitter” concept which is 
known as the ‘Dale’s principle’, though the popular English pharmacologist Henry Hallett 
Dale was not the inventor of this rule. In 1935 he published a lecture called “Pharmacology 
and nerve endings” hypothesizing that a neuron functions as a metabolic unit and a process 
occurring in the cell can influence all of the compartments of that neuron (Dale, 1935). This 
statement was then denoted as ‘Dale’s principle’ by the Australian neurophysiologist John 
Eccles in 1954 (Eccles et al., 1954; Lichtigfeld and Gillman, 1991; Strata and Harvey, 1999; 
Trudeau and Gutiérrez, 2007). First, in 1977, the Swedish physician Tomas Hökfelt 
formulated the ‘coexistence principle’ after the discovery that non-neurotransmitter peptide 
molecules like somatostatin, can exist with neurotransmitters in same peripheral and central 
neurons (Burnstock, 2004; Hökfelt et al., 1977). Today more than 100 neuropeptides are 
known. They can be cotransmitted together with neurotransmitters and act as pre- and/or 
postsynaptic neuromodulators of the release and actions of the principal neurotransmitters 
(Hökfelt et al., 1980). In 1998 Peter Jonas and others proved for the first time the corelease 
of two classical fast transmitters, GABA and glycine, from spinal cord interneurons (Jonas et 
al., 1998). This was a milestone in the research of chemical neurotransmission and opened 
the door to a new scientific field: cotransmission of two or more transmitters from a single 
neuron in the central nervous system and its functions in different regions of the brain.  
In the recent years, cotransmission of fast neurotransmitters was discovered in many parts of 
the brain. Gutierrez et al. described the cotransmission of GABA and glutamate from 
hippocampal granule cells (Gutiérrez, 2000, 2005). GABA and dopamine are simultaneously 
released by olfactory bulb short axon cells (Liu et al., 2013). Sulzer and Rayport found that 
ventral midbrain dopaminergic neurons cotransmit glutamate (Sulzer and Rayport, 2000). 
Furthermore, a cholinergic-glutamatergic cotransmission in the striatum was described 
(Guzman et al., 2011). Even in the retina, starburst amacrine cells cotransmit the two 
neurotransmitters acetylcholine and GABA (Lee et al., 2010). In the meantime, a lot of similar 
examples exist in literature and the actual state of research has been summarized as 
“cotransmission is more the rule than the exception in the central nervous system” (Trudeau 
and Gutiérrez, 2007). But what is the exact definition of “cotransmission”? A synapse 
consists of the signal sending part, the presynaptic neuron and the signal receiving part, the 
postsynaptic neuron. Both parts must fulfill specific properties for cotransmission. Regarding 
the presynapstic site cotransmission of neurotransmitters can occur from one neuron but 
from different synaptic terminals of this neuron (Lee et al., 2010; Fig. 1 A). Second, the 
cotransmitters could be released from different vesicles but from one synaptic terminal (Lee 
et al., 2010; Fig. 1 B). And finally, the cotransmitters could be coreleased from the same 
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vesicle (Burger et al., 1991; Wojcik et al., 2006); Fig. 1 C). The postsynaptic side must then 
be able to receive this dual signal from the presynaptic neuron. Many ways for transmitter 
actions on receptors or transporters of the postsynapse exist. First, the both transmitters 
could act on two different neurons, each containing only one type of receptor (Dugué et al., 
2005; Fig. 1 D). Second, the cotransmitters could act on one single postsynaptic neuron that 
has both required receptor types and can simultaneously receive both signals (Fig. 1 E). In 
this case it is important to consider the density and distribution of each receptor type as well 
as the receptor characteristics (ionotropic/metabotropic) with different functions. The 
cotransmitters could also influence the transmission of the other transmitter when they act as 
agonists (Fig. 1 F) or antagonists (Fig. 1 G) on the postsynapse (Lu et al., 2008; Singer, 
2008). In addition, it is described that cotransmitters could activate ionotropic or metabotropic 
channels on the presynaptic neuron resulting in feed-back control of transmitter release (Lim 
et al., 2000; Milanese et al., 2014; Romei et al., 2012; Fig. 1 H). The simultaneous activation 
of metabotropic receptors in addition to ionotropic receptors on the postsynapse can provoke 
second-messenger cascades and influence for instance neuronal development and synaptic 
plasticity (Karls and Mynlieff, 2015; Park et al., 2010; Fig. 1 I). 
This resulting complexity of signal transmission offered by the simultaneous release of two or 
more transmitters necessitates the investigation how cotransmission occurs in the different 
brain regions to further understand the function of cotransmitting neurons.  
 
1.2 Cotransmission of GABA and glycine 
γ-Aminobutyric acid (GABA) and glycine are the main inhibitory neurotransmitters in the 
central nervous system. In adult mammalians GABA is predominantly present in the 
forebrain whereas glycine is the main transmitter in the hindbrain. Cotransmission of GABA 
and glycine was found in the spinal cord, some regions of the brainstem and the cerebellum 
(Dugué et al., 2005; Jonas et al., 1998; Lu et al., 2008). These findings are based on the one 
hand on immunohistochemical studies and on the other hand on physiological 
measurements. GABA and glycine cotransmitting neurons (hereafter referred to as GgC 
neurons) were identified by immunohistochemistry showing the colocalisation of both 
transmitters, GABA and glycine (Dumba et al., 1998; Todd et al., 1996; Walberg et al., 1990; 
Yang et al., 1997) as well as the coexpression of marker proteins for GABAergic and 
glycinergic neurons, GAD65/67 and GlyT2 (Martin and Rimvall, 1993; Rousseau et al., 
2008). GAD65 and GAD67 are the two isoforms of the glutamate decarboxylase. These 
enzymes catalyze the decarboxylation of glutamate to synthesize GABA and thus control the 
filling of synaptic vesicles with GABA (Martin and Rimvall, 1993). GAD65 is directly involved 
in refilling of synaptic vesicles with newly synthesized GABA by functional coupling to the 
vesicles and VIAAT (Jin et al., 2003). The glycine transporter 2 (GlyT2) is the most important  
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Fig. 1: Spectrum of signalling variations offered by cotransmission. A: Cotransmission of two 
neurotransmitters from a single neuron but from different synaptic terminals. B: Both transmitters are 
cotransmitted from one synaptic terminal but different vesicles. C: Corelease of two transmitters when 
they share the same synaptic vesicle. D: Action of two coreleased transmitters on different 
postsynapses. E: The postsynapse possesses both required receptors and can receive the signal of 
both transmitters. F: One transmitter can act as agonist on the receptor of the other transmitter. G: 
One transmitter can also act as antagonist on the receptor of the other transmitter. H: The 
cotransmitters can activate metabotropic receptors on the presynapse and lead to a feed-back control 
of transmitter release. I: Besides the activation of ionotropic receptors the cotransmitters can bind to 
metabotropic receptors on the postsynapse and influence for example metabolism.   
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factor for a glycinergic phenotype (Aubrey et al., 2007; Rousseau et al., 2008). This 
membrane-associated transporter recaptures glycine from the synaptic cleft to maintain 
intracellular glycine levels (Aubrey et al., 2007).  
In addition, identification of GgC neurons was achieved by analysing inhibitory postsynaptic 
potentials (IPSCs) resulting from glycine receptor components together with GABAA receptor 
components (Dugué et al., 2005; Jonas et al., 1998; Lu et al., 2008). These 2-component 
IPSCs arise from the quantal corelease of GABA and glycine from one synaptic vesicle 
(Jonas et al., 1998). It is known that both transmitters share the same vesicular transporter 
(VIAAT) which transports GABA and glycine into synaptic vesicles (Burger et al., 1991a; 
Christensen et al., 1990, 1991). However, it is not yet clear what mechanisms control the 
differential uptake of GABA and glycine into the synaptic vesicles. Whether transport of both 
transmitters into vesicles occurs simply in a concentration-dependent manner or whether 
other regulatory mechanisms are involved is still a matter of debate (Apostolides and 
Trussell, 2013; Aubrey et al., 2007).  
The functional importance of simultaneous release of GABA and glycine is interpreted 
differently in a number of various studies. Since GABAergic and glycinergic IPSCs show 
different kinetics, a precise regulation of the time course of the postsynaptic conductance is 
achieved by the differential filling of synaptic vesicles (Jonas et al., 1998). Furthermore, 
GABA could lead to a feed-back regulation of transmitter release by the action on 
metabotropic GABAB receptors, which may not be possible at pure glycinergic synapses (Lim 
et al., 2000). A direct agonistic effect of GABA on postsynaptic glycine receptors was also 
observed, resulting in a shorter glycinergic IPSC kinetic and thereby to a temporally more 
precise inhibition (Lu et al., 2008). Furthermore, the combination of glycinergic and 
GABAergic responses may lead to a greater depolarisation and to the activation of voltage-
gated calcium channels. This calcium influx due to GABAA receptor activation may be 
important for neuronal development (Cherubini et al., 1991; Obrietan and van den Pol, 1995).  
These examples reflect the intricacy of the cotransmission of GABA and glycine and show 
the necessity for the detailed analysis of each neuronal system using GABA and glycine for 
signal transmission, for instance the respiratory centre of the brainstem. 
 
1.3 Generation of the respiratory rhythm 
Breathing requires a fine-tuned activity of different neuron groups resulting in alternating 
contractions of respiratory muscles. It is controlled by a complex neuronal network in the 
brainstem, the ventral respiratory group (VRG). The VRG is located in the ventral, lateral 
medulla near the Nucleus ambiguus and consists of a diffuse formation of neurons with local 
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accumulations. Different parts of the VRG can be distinguished: Specialized neurons in the 
rostral part function as central chemoreceptors that control breathing depending on 
respiratory gases. They measure the pH as well as the concentration of CO2 in the liquor and 
send their information to the Dorsal Respiratory Group and Nucleus tractus solitarii in the 
caudal part of the VRG. These neurons are the first integration station. They process all 
afferent input from the central chemoreceptors as well as the peripheral chemoreceptors 
(glomera carotica and aortica) and different reflexes (Hering-Breuer-Reflex, cough reflex, 
sneeze reflex) (Schmidt et al., 2004). Information is then sent to the Pre-Bötzinger Complex 
(PBC). Neurons of the PBC show a permanent alternate rhythmic activity (Feldman and Del 
Negro, 2006; Richter and Spyer, 2001; Richter D., 1996). They are responsible for the 
generation of the respiratory rhythm. Figure 2 shows a summary of the location and signal  
pathways of the respiratory centre. 
 
Fig. 2: Schematic representation of the respiratory centre, the Ventral Respiratory Group 
(VRG), in the lateral medulla of mice. The VRG can be separated into functional parts: Neurons for 
chemoreception (CR) are located in the dorsal VRG, followed by neurons of the Dorsal Respiratory 
Group (DRG) and Nucleus tractus solitarii (NTS) which process afferent input from central and 
peripheral chemoreceptors (CR). The oscillatory rhythm of the respiration is generated from neurons 
of the Pre-Bötzinger Complex (PBC) that innervate spinal cord motoneurons which finally send the 
signal to respiratory muscles. BC: Bötzinger Complex. Hc: hippocampus. 
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Many neurons of this respiratory network show pacemaker activity generating trains of 
rhythmic action potentials (Butera et al., 1999; Del Negro et al., 2002; Johnson et al., 1994; 
Paton et al., 2006). These intrinsic mechanisms are regulated by the synaptic control of other 
respiratory neurons, most importantly inhibitory interneurons (Brockhaus and Ballanyi, 1998; 
Onimaru et al., 1990; Pierrefiche et al., 1998; Winter et al., 2009). They are supposed to be 
crucial for the modulation but also the generation of the respiratory rhythm. Rhythm 
generation depends on synaptic interaction based on reciprocal inhibition of different 
interneurons (Richter et al., 1979; Rybak et al., 2007). The inhibitory interneurons of the PBC 
use GABA and glycine for signal transmission. Dysfunction of synaptic inhibition has drastic 
effects on the function of the respiratory rhythm generation. Mainly disturbance of the 
GABAergic inhibition caused by a loss of GAD67 (Asada et al., 1997; Kuwana et al., 2003) or 
both glutamate-decarboxylase isoenzymes GAD65 and GAD67 (Fujii et al., 2007) lead to 
perinatal breakdown of respiration. Similar effects were observed for mice lacking the 
vesicular transporter for GABA and glycine (vesicular inhibitory amino acid transporter, 
VIAAT; Fujii et al., 2007; Wojcik et al., 2006). Mice with a dysfunction of glycinergic inhibition 
are surprisingly viable over a short period of time. GlyT2-ko mice with a drastic decrease of 
glycine release die at the end of the second postnatal week showing a hyperekplexia similar 
phenotype (Gomeza et al., 2003). Mice lacking the postsynaptic glycine receptor die after the 
first postnatal week, but without disturbance of breathing (Büsselberg et al., 2001; 
Markstahler et al., 2002).  
These examples show the importance of inhibitory synapses for respiratory rhythm 
generation in the PBC. Future experiments have to further analyse the neuron populations 
responsible for inhibition in the PBC to finally clarify how these neurons contribute to the 
development and maturation of the rhythm-generating circuitry as well as associated 
pathologies, such as Sudden Infant Death Syndrome. 
 
1.4 The mouse as model organism for the analysis of different cell populations in-vivo 
A very important model organism for gene manipulation is the mouse (Beck et al., 2000). 
Besides humans, mice are the best characterized mammals whose genome is completely 
sequenced (C57Bl6, Waterston et al., 2002) The murine genome comprises about 27000 to 
30500 genes and 99 % of these genes have an equivalent in the human genome (Waterston 
et al., 2002). Physiological processes but also diseases can be investigated in mice because 
of the small size and easy handling as well as the short generation time. The progress in 
molecular biology lead to the extension and advancement of possibilities for the modification 
of the mouse genome and many mouse mutants were established. The possibility to modify 
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genes and therefore change protein expression in vivo allows analysing the function of 
proteins and helps to visualize specific proteins and cell populations for investigation.  
The genetic manipulation of mice can be achieved by different technical approaches. The 
first strategy is the directional modification of genes which can result in a gene deletion 
(knock-out) or a gene insertion (knock-in) in the gene locus of interest. This method involves 
the modification of embryonic stem cells, achieved by using homologous recombination 
(Thomas and Capecchi, 1987) or the CRISPR/Cas system (Jinek et al., 2012; Ochiai, 2015). 
The second strategy is the undirected insertion of genes using the transfection of 
recombinant viruses (Hellerman et al., 1984; Hirsch and Samulski, 2014; Miller and Rosman, 
1989) or the pronuclear microinjection of DNA into a mouse oocyte, where it will randomly 
integrate into the genome (Gordon and Ruddle, 1983; Gordon et al., 1980; McKnight et al., 
1983; Palmiter et al., 1982). This can result in variable expression of DNA constructs since 
the gene locus of integration plays an important role for expression levels (Feng et al., 2000). 
Restricted expression of the transgene can occur when the gene locus is for instance 
silenced (heterochromatin), while overexpression may lead to a not reliable phenotype of the 
transgene. These limitations can be minimized when Bacterial Artificial Chromosomes 
(BACs) are used for transgenesis (Heintz, 2001). BACs are large DNA vectors derived from 
the functional fertility plasmid (F-plasmid) of E.coli. They can contain large inserts in a single 
molecule, for instance whole eukaryotic genes, including all cis-acting regulatory elements. 
Using BACs for transgenesis the probability of transgene repression or undesired 
overexpression is much lower in comparison to small DNA constructs (Giraldo and Montoliu, 
2001). For manipulating the genome of mice, BACs carrying whole murine genes with their 
regulatory sequences are available in mouse databases (e.g. European Mouse Mutant 
Archive, Charles River, Source BioScience imaGenes).  
 
1.5 Conditional genetic modification of cell populations using the Cre-loxP system 
The generation of conditional cell-type specific mutants of the mouse as well as tracking of 
the fate of cells by an irreversible labelling using the Cre-loxP system has revolutionized 
biological research (Bockamp et al., 2008; Gu et al., 1993; Lewandoski, 2001; Tsien et al., 
1996). The Cre-loxP system consists of two components: the Cre recombinase (causes 
recombination) and the LoxP sequences (locus of crossover x from bacteriophage P1). The 
Cre recombinase was isolated from the bacteriophage P1 and is a member of the integrase 
family of site-specific tyrosine recombinases (Abremski et al., 1983; Argos et al., 1986; Sauer 
and Henderson, 1989). It catalyzes the conservative site-specific recombination between two 
identical 34 bp long loxP sites which are composed of 13 bp inverted repeats flanking an 8 
bp asymmetrical core sequence (Hamilton and Abremski, 1984; Sternberg and Hamilton, 
1981). Cre activity results in the deletion of the DNA sequence in between two loxP sites with 
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the same orientation leaving a single loxP sequence (Abremski et al., 1983). Catalysis of 
recombination is possible without additional proteins or cofactors which allows the function of 
Cre not only in bacteriophage P1 but also in transgenic mice (Abremski and Hoess, 1984; 
Abremski et al., 1983; Sternberg and Hamilton, 1981). This conditional gene targeting 
technology enables a cell type-specific deletion of genes by driving the expression of Cre 
recombinase under the control of a cell type-specific promoter (Branda and Dymecki, 2004; 
Lakso et al., 1992; Orban et al., 1992). Conditional expression of reporter genes, for instance 
fluorescent proteins, is achieved by the insertion of a loxP-flanked Stop cassette between 
promoter element and reporter gene. Expression of the reporter occurs only after excision of 
the Stop signal through Cre mediated recombination (Lakso et al., 1992). Once the stop-
cassette is deleted the reporter is constitutively expressed in cells that have or once had Cre 
activity (Fig. 3).  
 
Fig. 3: General principle of the Cre-mediated DNA recombination and cell-type specific reporter 
expression. A: Cre is expressed by a cell-type specific promoter in a specific cell population. B: The 
enzyme recognizes loxP sites (red triangles) within a DNA reporter sequence and leads to the deletion 
of the Stop cassette in between two loxP sites with the same orientation. C: After removal of the Stop 
signal the reporter protein, here RFP (Red Fluorescent Protein) is expressed exclusively in this 
specific cell type. Ubi P: ubiquitous promoter. 
 
 
An intrinsic limitation of the Cre-loxP recombination system is the cell-type specific promoter 
used for Cre expression. Many interesting cell populations cannot be defined unequivocally 
by the expression of one promoter and therefore a precise genetic modification without the 
simultaneous recombination in other cell populations is not feasible. A more precise genetic 
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targeting can be achieved by the Split-Cre system which is based on the functional 
complementation of Cre protein fragments (Hirrlinger et al., 2009a). As the name already 
indicates the Cre protein is split into two parts, an N-terminal part called NCre and a C-
terminal part named CCre. Each Cre part alone shows no enzymatic activity. However, when 
both parts are co-expressed in one cell they can associate and regain enzymatic activity 
which leads to DNA recombination. This system improves the local control of Cre 
recombination. 
To control the time-point of recombination by a ligand induced system the Cre recombinase 
was fused to the mutated ligand binding domain of the human estradiol receptor ERT2 
(Brocard et al., 1997; Feil et al., 1996; Metzger et al., 1995; Schwenk et al., 1998). The ERT2 
domain does not bind endogenous estradiol but is highly sensitive to nanomolar 
concentrations of tamoxifen or its metabolite 4-hydroxy-tamoxifen (Feil et al., 1997). In the 
absence of tamoxifen the fusion protein is captured by heat shock proteins (hsp90) and 
remains in the cytoplasm. After binding of the ligand tamoxifen to the ERT2 domain the heat 
shock proteins dissociate from the fusion protein which is then transported into the nucleus to 
catalyses DNA recombination. Such a ligand controlled system was established for the full 
Cre enzyme and is called CreERT2 system (Feil et al., 1997; García-Otín and Guillou, 2006). 
Transgenic mice expressing the CreERT2 in specific cell populations are available and well 
characterized (e.g. Gil-Sanz et al., 2015; Hirrlinger et al., 2006; Huang et al., 2014). In these 
mice recombination occurs after application of tamoxifen and is absent without tamoxifen. 
The ERT2 domain has also been fused to the Split-Cre parts NCre and CCre to obtain 
temporal control for the Split-Cre system. This “Split-CreERT2 system” showed the best 
recombination efficiency by fusing ERT2 to the C-terminus of NCre (NCreERT2) and to the 
N-terminus of CCre (ERT2CCre). Furthermore, a low recombination in the absence of 
tamoxifen and high activity of recombination in the presence of tamoxifen were described 
(Hirrlinger et al., 2009b).  
So far, experiments using Split-CreERT2 were performed only in cell culture. Therefore, one 
aim of this work was to investigate whether the Split-CreERT2 system also works in 
transgenic mice. The general principle of the ligand controlled cell-type specific mutation by 
split-CreERT2 is based on the generation of three mouse-lines. In the first line NCreERT2 is 
expressed under control of a first tissue-specific promoter. The second mouse-line expresses 
ERT2CCre under control of a second cell-type specific promoter. The third line carries a 
reporter gene consisting of an ubiquitous promoter and the loxP-flanked stop-cassette 
followed by a fluorescent reporter protein. Cross-breeding of these three mouse-lines 
generates triple-transgenic offspring. Only cells that show activity of both promoters 
coexpress the Cre parts. After the application of the inducer tamoxifen the DNA is processed 
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and the fluorescent reporter protein, for instance RFP, is exclusively expressed in a defined 
cell population (Fig. 4).  
 
 
Fig. 4: Local and temporal control of reporter expression offered by the Split-CreERT2 system. 
A: The Cre enzyme is separated into two parts, NCre (green circle) and CCre (blue circle). Both parts 
are fused to the ligand binding domain of the human estradiol receptor ERT2 (black circle). Expression 
of the fusion proteins is driven by two cell-type specific promoters (promoter 1 and 2) for the precise 
targeting of a distinct cell population. After translation the fusion proteins are captured by heat-shock 
proteins (hsp) and stay in the cytoplasm. B: Application of the inducer tamoxifen leads to the 
dissociation of the hsp resulting in the complementation of the Cre fragments NCreERT2 and 
ERT2CCre. The recombinase then recognizes the loxP sites (red triangles) and leads to the deletion 
of the loxP-flanked Stop cassette which results in the expression of the fluorescent reporter protein 
RFP (Red Fluorescent Protein). Ubi P: ubiquitous promoter. 
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2. Aim of the work and hypotheses 
Aim of the present work was the identification and characterisation of GABA and glycine 
cotransmitting (GgC) neurons in the Pre-Bötzinger Complex (PBC), a brain region crucial for 
the generation of the respiratory rhythm. To facilitate functional analysis of GgC neurons a 
novel transgenic mouse-line should be established allowing for the visualisation of GgC 
neurons in vivo and in living slice preparations without additional staining procedures. Taking 
advantage of this new tool, this work aimed at investigating the distribution of cotransmitting 
neurons in the PBC in different developmental stages before and after birth to characterize 
the amount of cotransmission at different ages. Furthermore, the inducible Split-CreERT2 
system should be used for the first time in transgenic mice to analyse the fate of GABA and 
glycine cotransmitting neurons by the irreversible staining of these neurons at a selected 
time-point in development.   
With these novel transgenic mouse-lines the present work provides tools for the analysis of 
GgC neurons in the PBC and contributes to the characterisation of this neuron type including 
the role for rhythm generation of the respiration. In this context, the following hypotheses 
should be addressed: 
1) GABA and glycine cotransmitting neurons exist in the PBC. 
2) The number of GgC neurons in the PBC changes during development. 
3) GgC neurons of the PBC differentiate to pure GABAergic or glycinergic neurons. 
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3. Material 
3.1 Oligonucleotides 
Oligonucleotides (Primer) were synthesized by MWG Biotech (Ebersberg) and provided as 
lyophilised powder after HPSF (High Purity Salt Free) purification. Stock solutions of 50 μM 
were prepared by solubilization in A. bidest and stored at -20°C. Prior to setting up PCR 
reactions, stock solutions were diluted to 5 μM. Tab. 1 shows the sequence and position of 
all used oligonucleotides. 
 
Tab. 1: Overview of all used oligonucleotides (s: sense direction; as: anti-sense direction). AP: 
Alkaline Phosphatase. β-Gal: β-Galactosidase. HA: Homology arm. 
Number s/as Sequence (5’ → 3’)  Position 
Standard cloning/BAC modification 
JH0287 as TCTCTCTAGAGAATTGATCCCCTCAGGGAGCAGTGGCCGTCTC AP 
JH0288 s GAGACCCGGGATGGACCCTGTTGTGCTGCAAAGG β-Gal 
JH0289 as TCTCTCTAGAGAATTGATCCCCTTACTTCTGGCACCACACCAGCTGATA β-Gal 
JH0314 s GAGAGTATACATGGGATCTGATCTGGGGCCTCG AP 
JH0344 s GAGAGCTAGCGAGAATTTAAATGTCTGGAATCAAGTGGAGAGAATGTAAG HA1 GlyT2 
JH0345 as 
TCTCGGATCCGCCCGGGCTCAGATCCTCTTCAGAGATG
AGTTTCTGCTCCTGCAAACACAATGTCAAGTTCGTGCAA
AA 
HA1 GlyT2 
JH0352 s GAGAGCTAGCGAGAATTTAAATAGAACCACTTTTGCTCGGCAGCAG HA1 GAD65 
JH0353 as TCTCGGATCCGCCCGGGCTCTTATCGTCGTCATCCTTGTAATCCATGGGTTCTGCTAGACTGGCG HA1 GAD65 
JH0469 s 
GAGATTATAATGGTTACAAATAAAGCAATAGCATCACAAA
TTTCACAAATAAAGCATTTTTTTCACTGCCTAGTTGTGGT
TTGTCCAAACTCATC 
FRT-neo-
FRTcassette 
JH0471 s GAGAGGCGCGCCGTAGGAAAATCAGGACCTGCAGCG HA2 GAD65 
JH0473 s GAGAGGCGCGCCGTAAGCAGGTCACAAGCGGCCC HA2 GlyT2 
JH0495 as TCTCGAGGAAGCGGAAGAGCGtcGTATACTCGGCGCGCCCGAAGTTATATTATGTACCTGACTGATGAAG 
FRT-neo-FRT 
cassette 
JH0497 as TCTCGGCGCGCCACCTGTTGCGTGCAGAAACGCGTAG HA2 GAD65  
JH0498 as TCTCGGCGCGCCGATGACTGGGTGGCTGAGTTCCTAC HA2 GlyT2  
JH0537 as TCTCATCGATCGCCTTAAGATACATTGATGAGTTTGGAC tdTomato 
JH0538 s 
GAGACACTACGTGGAATTTAAATGGCAGCTTGCCACAGC
CACTTGGAGGCGACCAGCGCCAGTCTAGCAGAACCCAT
GGTGAGCAAGGGCGAGGAGGTC 
tdTomato 
JH0539 as 
TCTCCCGCGGTCATTTAAATTGCAAACCCTAAACCACCC
ACAAAGCTCTCCCGCTGCAGGTCCTGATTTTCCTACCGA
AGTTATATTATGTACCTGACTGATGAAG 
FRT-neo-FRT 
cassette 
 
 
 
 
                                                                                                                                     Material 
13 
 
Tab.1: Continued. 
Number s/as Sequence (5’ → 3’) Position 
BAC generation and verification 
JH0309 s CAAATAAAGCAATAGCATCACA SV40-PolyA 
JH0310 as ATCTTAGCGCAGAAGTCATGCCCG NCre 
JH0365 s GGATGTGCCTTCCATAAGTTCTCTCC BAC-GlyT2   5'A  
JH0366 as GGAAGGAAACAGGTACGGAAGGGTAG BAC-GlyT2 5'A 
JH0367 s CCTAGGGACAGTACCACCCACAGT BAC-GlyT2 5'B 
JH0368 as CTGCTATGAGCAATTAGCAGGCCACTT BAC-GlyT2 5'B 
JH0369 s TTGGGCCATGTGGTGAAGGCCAG BAC-GlyT2 3'A 
JH0370 as GGTAGACCTGTTGGTCCAGCAGAGAAT BAC-GlyT2 3'A 
JH0371 s GTGCCTGGACCTGGAATGTGTGC BAC-GlyT2  Ex 2  
JH0372 as AGCATACGTGCACCCGCCAGG BAC-GlyT2  Ex 2  
JH0373 s TGTATATCCTTGGACCAGGGAGTGGC BAC-GAD65 5'A 
JH0374 as GCAGTACCCCACTCCCAGTACCAA BAC-GAD65 5'A 
JH0375 s TCTTCCTCCCAAAGTCCTAGACCTCCA BAC-GAD65 5'B 
JH0376 as TGGGTTTCCGAGGTCGTCTTGGAG BAC-GAD65 5'B 
JH0377 s CACCCATCCCTGGACAAGTGGC BAC-GAD65 3'A 
JH0378 as GCACCGTCTGTTTGGTCTGTGG BAC-GAD65 3'A 
JH0379 s CATCTGCCTGCCCCTCAACTCC BAC-GAD65 3'B 
JH0380 as TCCGCTGCACTCACTCTTGTCAGT BAC-GAD65 3'B 
JH0381 s CGCCTGTGGCTGGGTCAGCA BAC-GAD65 Ex 1 
JH0382 as GCAGCTCACAACGCCGCCCTT BAC-GAD65 Ex 1  
JH0383 s GTCTGGAATCAAGTGGAGAGAATGTAAGG BAC-GlyT2 5'C 
JH0384 as CTGCAAACACAATGTCAAGTTCGTGCAAAA BAC-GlyT2 5'C 
JH0385 s AGAACCACTTTTGCTCGGCAGCAG Bac-GAD65 5'C 
JH0386 as CATGGGTTCTGCTAGACTGGCG Bac-GAD65 5'C 
JH0407 as GGTGCTGGACAGAAATGTGTACACTC ERT2 
JH0419 as GTCAAAGCTTTGATGATCAGCCTAGCC BAC-GAD65 
JH0499 s CGTTGGCTACCCGTGATATT kanamycin 
JH0505 as GGTCAGTAAGCCCATCATCG ERT2 
JH0515 s CCCACTTCTGGCAAGTCTTT BAC-GlyT2 
JH0516 as TGCAGAGGTAAAGGGAGGTG BAC-GlyT2 
JH0517 s AGTCAAAACCTGGACGATGG BAC-GAD65 
JH0518 as CTTGGCCACTGATTCTGGTT BAC-GAD65 
JH0519 as TCTCTGCCCAGAGTCATCCT CCre 
JH0525 as AGGGGGAGGTGTGGGAGGTT SV40-PolyA 
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Tab.1: Continued. 
Number s/as Sequence (5’ → 3’) Position 
Multiplex nested scPCR 
JH0323 s GTGGATGCTGCTTGGGGT GAD 
JH0325 as GAAGAAGTTGACCTTGTCCC GAD 
JH0326 s GTATTTCTGCATCTGGAAGG GAT 
JH0330 as GAAGCCCAAGATGGAGAAGA GAT 
JH0331 s GTGGGATTTGAAAACCAGATCAA GAD67 
JH0332 as TTTTCTCGTCGCTCAGGGC GAD67 
JH0333 s TACTGGGTTTGAGGCACACATT GAD65 
JH0334 as GCGGCTCATTCTCTCTTCAT GAD65 
JH0335 s TATCATCCTGTTCTTCCGTGGA GAT1 
JH0336 as AGGAGTTGATGCAGCAAACGAT GAT1 
JH0421 s GCAAAGTCAACATTGAGAATGTG GlyT2 
JH0422 as AGATACATTTTTATCACGAACATAATC GlyT2 
JH0423 s CATCTTTTTTCTGATGCTTCTCAC GlyT2 
JH0424 as TCATCATCTCGATGTCTTCACAGA GlyT2 
JH4262 s GATATCGCTGCGCTGGTCGTC β-Actin 
JH4263-2 s CGTGGGCCGCCCTAGGCACCA β-Actin 
JH4264 as CATGGCTGGGGTGTTGAAGGTC β-Actin 
JH4265 as CTTAGGGTTCAGGGGGG β-Actin 
Genotyping 
JH511 s GTGCTGAGGGCTGTGGTAG NCre/NCreERT2 
JH414 as GCGTTCGCCAACTAATTTCTTTAATCTGG NCre/NCreERT2 
JH371 s GTGCCTGGACCTGGAATGTGTGC BAC-GlyT2 
JH372 as AGCATACGTGCACCCGCCAGG BAC-GlyT2 
1957 s GCCGCTACCCCGACCAC EGFP 
JH521 as CTCCATCAGGGATCTGACTTGGTCAA CCre 
JH131 as TGCCTGATGTGGGAGAGGAT ERT2CCre 
JH402 s GTGCAGGGTCGAGGCAAAGGCA BAC-GAD65 
JH420 as GGACAGGATGTCCCAGGCGAAG tdTomato 
3735 s AAAGTCGCTCTGAGTTGTTAT (Soriano 1999) Ai14 wild-type 
3737 as GGAGCGGGAGAAATGGATATG (Soriano 1999) Ai14 wild-type 
JH526 S TACGGCATGGACGAGCTGTACAAGTAA Ai14 transgene 
JH527 as CAGGCGAGCAGCCAAGGAAA Ai14 transgene 
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3.2 Antibodies 
Antibody stock solutions were prepared according the manufacturer’s instructions and stored 
at 4 °C or - 20 °C. The antibodies used for this study are listed in Tab. 2.  
 
Tab. 2: Primary and secondary antibodies used for immunohistochemistry 
Antibody Host Dilution Manufacturer 
Primary antibodies 
anti-GABA rabbit 1:5000 Sigma-Aldrich, Taufkirchen, Germany 
anti-GAD65 mouse 1:1000 Millipore, Darmstadt, Germany 
anti-GAD67 Mouse 1:500 Millipore, Darmstadt, Germany 
anti-GlyT2 Guinea pig 1:5000 Millipore, Darmstadt, Germany 
anti-glycine Rat 1:5000 Biozol, Eching, Germany 
anti-β-Gal Rabbit 1:2000 MP Biomedicals, Santa Ana, USA 
anti-ERα Rabbit 1:1000 Santa Cruz, Heidelberg, Germany 
anti-Parvalbumin Rabbit 1:5000 Swant, Marly, Schweiz 
Anti-ChAT Goat 1:500 Millipore, Darmstadt, Germany 
anti-Iba1 Rabbit 1:200 Wako, Osaka, Japan 
anti-Calbindin Mouse 1:1000 Sigma-Aldrich, Taufkirchen, Germany 
anti-Calretinin Rabbit 1:1000 Millipore, Darmstadt, Germany 
anti-GFAP Rabbit 1:500 Dako, Hamburg, Germany 
anti-DsRed Rabbit 1:1000 Clontech, Saint-Germain-en-Laye, France 
anti-Somatostatin Rabbit 1:250 Peninsula Laboratories, San Carlos, USA 
Secondary antibodies 
anti- Rabbit-Cy3 IgG Goat 1:1000 Dianova, Hamburg, Germany 
anti- Rabbit-Cy5 IgG Goat 1:1000 Dianova, Hamburg, Germany 
anti- Rabbit-Cy2 IgG Goat 1:1000 Dianova, Hamburg, Germany 
anti-Goat-Cy5 IgG Donkey 1:500 Dianova, Hamburg, Germany 
anti-Guinea Pig-Cy3 IgG Goat 1:1000 Dianova, Hamburg, Germany 
anti-Mouse-Cy2 IgG Goat 1:1000 Dianova, Hamburg, Germany 
anti-Mouse-Cy3 IgG Goat 1:1000 Dianova, Hamburg, Germany 
anti-Mouse-Cy5 IgG Goat 1:1000 Dianova, Hamburg, Germany 
anti-Rat-A488 IgG Goat 1:500 Dianova, Hamburg, Germany 
 
 
3.3 Transgenic mouse lines 
Mouse-lines were bred in the animal facility of the Medical Faculty as well as the Faculty for 
Bioscience, Pharmacy and Psychology of the University of Leipzig and treated in accordance 
with the German Protection of Animals Act (TSchG §4 Abs. 3) and with the guidelines for the 
welfare of experimental animals issued by the European Communities Council Directive of 
24. November 1986 (86/609/EEC). Mice were housed in a 12h/12h light dark cycle with 
access to food and water ad libitum. All generated mouse-lines were crossbred to the wild-
type strain C57B6 to ensure a proper genetic background.  
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Tab. 3 shows all mouse-lines generated in the present work and additional established lines 
used for the project. 
 
Tab. 3: Overview of all used mouse-lines. 
Transgenic mouse lines Expression pattern Reference 
TgN (GAD65-tdTomato) GABAergic cells express tdTomato Besser et al.2015 
TgN (GlyT2-CCre) Glycinergic cells express CCre Present work 
TgN (GAD65-NCre) GABAergic cells express NCre Present work 
TgN (GlyT2-ERT2CCre) Glycinergic cells express ERT2CCre Present work 
TgN (GAD65-NCreERT2) GABAergic cells express NCreERT2 Present work 
TgN (GlyT2-EGFP) Glycinergic cells express EGFP Zeilhofer et al. 2005 
TgH (ROSA26-STOPflx-RFP)1, 
Ai 14 reporter 
Expression of RFP after split- Cre-
mediated DNA recombination Madisen et al. 2010 
COFLUOR 
= cross breeding of 
TgN (GlyT2-EGFP)  
TgN (GAD65-tdTomato) 
GABAergic cells express tdTomato 
Glycinergic cells express EGFP 
Cotransmitting neurons express both  
tdTomato and EGFP 
Present work 
COTRIND 
= cross breeding of 
TgN (GlyT2-ERT2CCre) 
TgN (GAD65-NCreERT2)  
TgH (ROSA26-STOPflx-RFP)1 
Neurons cotransmitting at the time of 
Tamoxifen injection will be labeled 
irreversibly by RFP expression from the 
Ai14 reporter  
 
Present work 
 
 
3.4 Antibiotics 
Stock solutions of all antibiotics were stored at -20ºC. For selective LB medium, the 
antibiotics were dissolved in LB medium to the indicated working concentration in Tab. 4. 
 
 
Tab. 4: Antibiotics used for selective culturing of bacteria.  
Antibiotic Stock solution Working solution 
Chloramphenicol 30 mg/ml dissolved in ethanol 15 µg/ml for BACs, 50 µg/ml for high-copy plasmids 
Tetracycline 10 mg/ml dissolved in 75% ethanol 3 µg/ml for pRedET 
Kanamycin 30 mg/ml dissolved in A. dest. 15 µg/ml for BACs, 50 µg/ml for high-copy plasmids 
Ampicillin 50 mg/ml dissolved in A dest. 50 µg/ml for high-copy plasmids 
 
                                                          
1
 The mouse-line Ai14 is described to express tdTomato after Cre-mediated recombination. To avoid a mix up of 
COTRIND mice with TgN(GAD65-tdTomato) in this work the reporter protein for irreversible staining of GgC 
neurons is denominated RFP.  
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3.5 Commercial reaction systems/Kits 
Invisorb Spin Tissue Mini Kit     Invitek (Berlin, Germany) 
Superscript III Reverse Transcriptase    Invitrogen (Karlsruhe, Germany) 
QIAprep Spin Miniprep/Midiprep/Maxiprep Kit   Qiagen (Hilden, Germany) 
QIAquick gel extraction Kit      Qiagen, (Hilden, Germany) 
BAC DNA purification Kit NucleoBond 100  Macherey-Nagel (Düren, 
Germany) 
Counter Selection BAC Modification Kit   Genebridges (Heidelberg,      
Germany 
 
3.6 Hardware/Equipment 
Fluorescence microscope Axiovert 200    Zeiss (Jena, Germany) 
Fluorescence microscope AxioObserver.Z1   Zeiss (Jena, Germany) 
Confocal Laser Scanning Mikroscope (LSM 700)  Zeiss (Jena, Germany) 
DNA Engine Peltier Thermal Cycler     Bio-Rad (München, Germany) 
Thermal Cycler C1000     Bio-Rad (München, Germany) 
Thermal Cycler S1000     Bio-Rad (München, Germany) 
Gene Pulser II      Bio-Rad (München, Germany) 
Pulse Controller Plus      Bio-Rad (München, Germany) 
Gel electrophoresis system PowerPac300    Bio-Rad (München, Germany) 
NanoDrop spectrophotometer ND-1000    Peqlab (Erlangen, Germany) 
UV-Gel documentation system    Intas (Göttingen, Germany) 
Vibratome VT 1000S       Leica (Nussloch, Germany) 
Dissecting set       FST (Heidelberg, Germany) 
Shaker Unitwist       Uniequip (München, Germany) 
Thermomixer comfort      Eppendorf (Hamburg, Germany) 
Centrifuge 5810R       Eppendorf (Hamburg, Germany) 
Table centrifuge Biofuge fresco     Heraeus (Mannheim, Germany) 
Vortex Mixer 7-2020       neoLab (Heidelberg, Germany) 
Water bath Unitherm WA6     Uniequip (Planegg, Germany) 
Water bath Thermo-Temp  Lauda (Lauda-Königshofen,    
Germany) 
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4. Methods 
4.1 Molecular cloning – standard methods 
The generation of targeting vectors for the modification of Bacterial Artificial Chromosomes 
was carried out using molecular cloning techniques. Molecular cloning was performed 
according published standard methods (Sambrook et al., 1989) or the manufacturer’s 
instructions. Sequence analysis, development of cloning strategies and primer design were 
done using Lasergene 12 (DNA Star, Madison, USA), the sequence data bank at 
http://www.ncbi.nlm.nih.gov/nuccore/ as well as the Basic Local Alignment Search Tool 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). The melting temperature of primers was controlled 
using the program OligoCalculator (http://mcb.berkeley.edu/labs/krantz/tools/oligocalc.html). 
Amplification of DNA fragments by Polymerase Chain Reaction (PCR) was performed using 
Pfu DNA polymerase (Thermo Scientific, Braunschweig, Germany), Red Taq DNA 
Polymerase (Sigma Aldrich, Taufkirchen, Germany) and Fast Start Taq DNA Polymerase 
(Roche, Berlin, Germany) according the manufacturer’s instructions. For cloning of the 
targeting vectors the following DNA fragments were amplified: 
 
Tab. 5: DNA fragments generated for targeting vector construction. 
Gene/DNA fragment Product size [bp] Primer Template 
Human PlacentalAlkaline 
Phosphatase 1625 JH314/JH287 pZAP 
Beta-Galactosidase 3119 JH288/JH289 pWhere 
Homologyarm GlyT2-1 757 JH344/JH345 BAC-GlyT2 clone RP23-365E4 
Homologyarm GlyT2-2 1080 JH473/JH498 BAC-GlyT2 clone RP23-365E4 
Homologyarm GAD65-1 718 JH352/JH353 BAC-GAD65 clone RP23-407K8 
Homologyarm GAD65-2 1126 JH471/JH497 BAC-GAD65 clone RP23-407K8 
FRT-Kana-FRT-cassette 2014 JH469/JH495 pL451-DsRed 
TdTomato-HA1-GAD65 1810 JH538/JH537 pCMV-tdTomato 
FRT-Kana-FRT-HA2-GAD65 2049 JH469/JH539 pL451 
 
 
Size of PCR products was analyzed using agarose gel electrophoresis. DNA extraction was 
performed with the Qiaquick Gel Extraction Kit (Qiagen, Hilden, Germany) and purified DNA 
stored at -20°C. Digestion of DNA was carried out using type-II restriction endonucleases 
(Thermo Scientific, Braunschweig, Germany; New England Biolabs, Frankfurt/Main, 
Germany) according to manufacturer’s instructions. Blunt ends of DNA fragments were 
generated by Klenow fragment (Thermo Scientific, Braunschweig, Germany). 
Dephosphorylation of 5’-DNA ends was performed with alkaline phosphatase (Roche, Berlin, 
Germany) according to manufacturer’s protocol. For ligation of vectors with DNA fragments 
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the T4 DNA ligase (Thermo Scientifc, Braunschweig, Germany) was used in compliance with 
the manufacturer’s instructions. 1µl polyethylenglycol was added to the reaction mix to 
increase the ligation efficiency. Expansion of DNA vectors was achieved by heat shock 
transformation into chemical competent E. coli DH5α. Selection of successfully transformed 
bacteria was carried out using LB-agar plates with the appropriate antibiotics. Preparation of 
vector DNA was performed using the Mini and Midi Plasmid Kits from Qiagen (Hilden, 
Germany) according to the manufacturer’s instructions. The concentration and purity of the 
extracted DNA was measured with the Nanodrop 2000 from Thermo Scientific. Sequence 
analysis was carried out in the core unit of the IZKF of the University of Leipzig. DNA 
sequence was controlled with the programs Chromas Lite and Lasergene 12 (DNA Star, 
Madison, USA), 
 
4.2 Multiplex nested single-cell RT-PCR 
Note: Patching of green glycinergic neurons from TgN(GlyT2-EGFP) mice (Zeilhofer et al., 
2005) and harvesting of cytosol from single neurons was performed by Prof. Dr. Swen 
Hülsmann and Jamilur Rahman at the Institute of Neurophysiology and Cellular Biophysics in 
Göttingen, whereas the establishment of the multiplex nested single-cell RT-PCR is part of 
the present work. 
  
 4.2.1 Patching of respiratory cells and Reverse transcription 
Preparation of acutely isolated brain slices from TgN(GlyT2-EGFP) mice, identification of 
EGFP-expressing respiratory neurons as well as the establishment of whole-cell recordings 
to harvest cytosol from single cells was carried out as described in Rahman et al., 2013. The 
cytoplasm from one cell was ejected immediately after retraction of the pipette into a 
polymerase chain reaction (PCR) tube containing reverse transcriptase buffer (Invitrogen, 
Karlsruhe, Germany), 100 µM of each dNTP (Thermo Scientific, Braunschweig, Germany), 5 
µM of random hexamer primers (Thermo Scientific, Braunschweig, Germany), 10 mM of 
dithiothreitol (Invitrogen, Karlsruhe, Germany), and 2 U of RNAseOUT (Invitrogen, Karlsruhe, 
Germany); 0.5 µl of reverse transcriptase Superscript III (200 U/µl; Invitrogen, Karlsruhe, 
Germany) was added immediately to initiate the reverse transcription reaction in a final 
volume of 10 µl. After incubation for 1 h at 50 °C, samples were frozen until further 
processing.  
 
 4.2.3 Multiplex nested single-cell PCR 
The presence of mRNAs coding for proteins specific for GABAergic and/or glycinergic 
neurons was analyzed with a two-step nested PCR. The first PCR was carried out as a 
multiplex PCR in a final volume of 50 µl containing the reverse transcription reaction, 1.1 mM 
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of MgCl2, primers (Tab. 6, 0.1 µM of actin primers and 0.13 µM of all other primers), 200 µM 
of each dNTP, 10% dimethylsulfoxide, and 2.5 U of RedTaq Polymerase (Sigma Aldrich, 
Taufkirchen, Germany), with the following protocol: 3 min at 94 °C, followed by 40 cycles with 
30 s at 94 °C, 30 s at 49 °C, 1 min at 72 °C and a final elongation of 10 min at 72 °C. For the 
second PCR, amplification was performed separately for all of the transcripts investigated. 3 
µl of the PCR product of the first PCR were added to each reaction mix containing 1.1 mM 
MgCl2, primers (0.25 µM each, Tab. 6), 200 µM of each dNTP, 10% dimethylsulfoxide, and 
2.5 U of Red- Taq Polymerase, giving a final volume of 50 µl. The temperature cycling 
protocol was the same as for the first round of PCR. Products were analyzed with gel 
electrophoresis. The PCR protocol was validated by using 10 pg of total RNA isolated from 
brainstem and hippocampus instead of cytosol harvested during electrophysiology (one cell 
contains around 50 pg of RNA, (Ringborg, 1966), which showed successful detection of all 
mRNAs investigated (data not shown). 
 
Tab. 6: Primers used for multiplex nested PCR. Product sizes (bp) are given in 
parentheses.  
Transcript Primer for first PCR Primer for second PCR 
GAD67 JH0323/325 (583) JH0331/332 (189) 
GAD65 JH0323/325 (583) JH0333/334 (184) 
GAT1 JH0326/330 (354) JH0335/336 (238) 
GlyT2 JH421/422 (625) JH0423/424 (311) 
β-Actin JH4262/4264 (387) JH4263-2/4265 (238) 
 
 
4.3 Generation of transgenic mice 
All transgenic mouse-lines established in the present work were generated using Bacterial 
Artificial Chromosomes (BACs). Targeting of GABAergic neurons was achieved by modifying 
a BAC containing the entire mouse GAD65 gene (BAC-GAD65). Manipulation of glycinergic 
neurons was performed with a BAC containing the whole mouse GlyT2 gene (BAC-GlyT2). 
In the subsequent paragraphs 4.3.1 and 4.3.2 the general principle of BAC identification and 
modification is described followed by the detailed description of BAC-GAD65 and BAC-GlyT2 
as well as the targeting constructs and modification strategy (4.3.2.1, 4.3.2.2). 
 
 4.3.1 Identification and source of BACs 
BAC-GAD65 clone 407K8 and BAC-GlyT2 clone RP23-365E4 from the mouse C57/Bl6 BAC 
library RPCI-23 (Research Genetics Inc., Huntsville, AL) were identified by using the 
ENSEMBL database of the Wellcome Trust Sanger Institute (http://www.ensembl.org). 
BAC-GAD65 clone 407K8 comprises 208,325 bp (base 22,549,829 to 22,758,153 of 
chromosome 2) including the whole GAD65 gene with all known 16 exons and additional 72 
                                                                                                                                    Methods 
21 
 
kb of the 5’ upstream region containing the presumptive GAD65 promoter elements as well 
as 64 kb 3’ downstream of exon 16. This BAC was obtained from Source Bioscience 
imaGenes (Berlin, Germany). BAC-GlyT2 clone 365E4 comprises 179,508 bp (38,423,556 to 
38,603,063 of chromosome 7) and contains the entire GlyT2 gene including 16 exons and 
105 kb of the 5’ upstream region containing the putative GlyT2 promoter elements as well as 
21 kb 3’ downstream of exon 16. BAC-GlyT2 was kindly provided by Dr. Volker Eulenburg 
(Institute for Biochemistry, University of Erlangen-Nürnberg). Sequence analysis and 
development of BAC cloning strategies were carried out using Lasergene 12 (DNA Star, 
Madison, USA), the sequence data bank at http://www.ncbi.nlm.nih.gov/nuccore/ as well as 
the Basic Local Alignment Search Tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
 
 4.3.2 Recombineering strategy – modification of BACs  
Because of their size, BACs cannot be modified applying conventional cloning methods 
which rely on the use of restriction enzymes and in vitro purification steps. Thus, the 
modification of BACs was performed using homologous recombination. Homologous 
recombination is a type of genetic recombination in which nucleotide sequences are 
exchanged between DNA molecules at identical sequences present in both DNA molecules 
(so called homology regions or homology arms). In the present work this technique was used 
to insert target sequences into BACs thereby to exchange the endogenous open reading 
frames (ORFs) of the GlyT2- and GAD65-gene by artificial ORFs. Homologeous 
recombination occurs in the presence of specific lambda phage recombination proteins, 
called Red α, Red β and Red γ. Red α is a 5’ - 3’ exonuclease whereas Red β functions as a 
DNA annealing protein and Red γ inhibits the Rec BCD exonuclease activity of E.coli. 
Coexpression of these proteins results in recombination when two DNA molecules share 
homology regions (GeneBridges, Heidelberg, Germany). Therefore, for the modification of 
BAC molecules, the target genes must be flanked by homology arms that have an identical 
nucleotide sequence to the target region within the BAC (compare Fig. 5). The recombination 
proteins were expressed from the plasmid pRed/ET that carries the lambda phage redγβα 
operon expressed under the control of the arabinose-inducible pBAD promoter (Guzman et 
al., 1995). The pBAD promoter is regulated by the product of the araC gene (Schleif, 1992). 
AraC is a transcriptional regulator that forms a complex with L-arabinose which allows 
transcription to begin. In the absence of arabinose, transcription is blocked by the AraC 
dimer.  
 
For recombineering. BAC-DNA was first transformed into E. coli Top10 bacteria: 30 µl 
of E. coli Top10 overnight culture were inoculated in fresh 1.4 ml LB medium (5 g/l yeast 
extract, 10 g/l peptone, 10 g/l NaCl) before incubating for 2 h at 37°C with rigorous shaking 
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(1000 rpm). To prepare cells for electroporation, the culture was centrifuged for 30 s at 
11200 g in a cooled benchtop centrifuge at 0°C. The supernatant was discarded and the 
pellet was resuspended with 1 ml cooled A. dest. on ice. To wash cells, centrifugation and 
resuspension was repeated once. Finally, most of the supernatant was discarded and the 
cells were resuspended in the remaining 30 µl of H2O. The cells were kept on ice during all 
steps. 2 µl of BAC-DNA (approximate concentration 1 µg/µl) were added to the cell 
suspension and the mix transferred to a pre-cooled 1 mm electroporation cuvette. 
Electroporation was performed at 10mF, 600 Ohms and 1350 V with a 5 ms pulse. Cells 
were resuspended in 1 ml LB medium without antibiotics, returned to a microfuge tube and 
incubated at 37°C for 70 min while shaking at 1000 rpm. 100 µl cells were streaked on LB 
agar plates containing Chloramphenicol (cam, 15 µg/ml) as the BACs contained a 
chloramphenicol resistance cassette. Plates were incubated at 37°C overnight. 
In a second step, the plasmid pRed/ET carrying the coding sequences for 
recombination proteins, was transformed into E coli Top10 containing the BAC. Cells were 
prepared for electroporation as described above. 1 µl of plasmid DNA (approx. 10 ng) was 
added to the cell suspension and electroporation was carried out as described above. 100 µl 
of cell suspension were streaked on LB agar plates containing cam (15 µg/ml; resistance 
cassette present on the BAC) and tetracyclin (tet, 3 µg/ml; resistance cassette present on the 
pRed/ET plasmid). Plates were incubated at 30°C overnight. 
In a third step the target gene fused to kanamycin resistance and flanked by 
homology arms was transformed into E coli Top10 carrying the BAC and the pRed/ET 
plasmid. One colony was inoculated in 1 ml LB medium with cam and tet. This culture was 
incubated over night at 30°C with shaking. The following day, 30 µl of overnight culture was 
inoculated in fresh 1.4 ml LB medium with cam and tet before incubating for 2 h at 30°C and 
1000 rpm shaking. To induce the expression of the pRed/ET recombination proteins 50 µl 
10% (w/v) L-arabinose (in ddH2O, Sigma Aldrich) was added to the culture (final 
concentration 0.35% (w/v) = 23 mM) and the cells incubated at 37°C for 1 h with shaking. 
Then cells were prepared for electroporation as described above. 100 to 200 ng/µl of DNA 
containing the target gene and kanamycin resistance (see below Fig. 5 C, E and Fig. 6 C, E) 
were added and electroporation was carried out as described above. Cells were 
resuspended in 1 ml LB medium without antibiotics, returned to a microfuge tube and 
incubated at 37°C for 70 min, shaking at 1000 rpm. During this culturing step recombination 
occurs and the target gene with kanamycin resistance is inserted into the BAC. 100 µl of cell 
suspension were streaked on LB agar plates containing cam and kanamycin (15 µg/ml) for 
selection of BACs carrying the target gene with kanamycin resistance. Plates were incubated 
at 37°C for about 24 h to obtain large colonies. E. coli clones with successful recombined 
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BACs were identified using colony PCR with the primers in Tab. 7. For colony PCR single 
colonies were picked from the plate and transferred directly into the PCR reaction mix.  
In a final step the kanamycin resistance was deleted using the Flp-mediated site-
directed recombination in E. coli. The Flp recombinase is encoded on the low copy plasmid 
p707-FLPe (GeneBridges, Heidelberg, Germany). The flpe gene is driven by the λR 
promoter which is under control of the heat labile cI857 repressor. A shift of temperature from 
30°C to 37°C results in transient Flp recombinase expression. The plasmid p707-FLPe was 
first transformed into E. coli carrying the modified BAC with the target gene and FRT-flanked 
kanamycin resistance. The procedure was the same as described for pRed/ET. Successfully 
transformed bacteria were cultured at 30°C on LB agar plates with cam (15 µg/ml; resistance 
cassette present on the BAC) and tet (3 µg/ml; resistance cassette present on p707-FLPe 
plasmid. For Flp recombination one single colony was inoculated in 1 ml LB with cam and 
incubated at 30°C for 2h and 800 rpm shaking. Then the temperature was increased from 
30°C to 37°C and the cells incubated for 4 hours at 37°C with shaking. During this step 
expression of flpe gene is induced and the Flp recombinase leads to the deletion of the 
kanamycin resistance in between the FRT-sites. Successful deletion of the kanamycin 
resistance was verified by colony PCR with the primers listed in Tab. 7. 
 
Tab. 7: Verification of successful modified BACs by colony PCR with the 
listed primers. 
Insert/BAC Primer Product size (bp) 
Insertion of target gene with kanamycin resistance into BAC 
TdTomato-kana in BAC-GAD65 JH0499/419 590 
NCre-IRES-AP-kana in BAC-GAD65 JH0517/310 JH0499/518 
1457 
1786 
NCreERT2-IRES-AP-kana in BAC-
GAD65 
JH0517/505 
JH0499/518 
1514 
1786 
CCre-IRES-AP-kana in BAC-GlyT2 JH0515/519 JH0499/516 
1787 
1722 
ERT2CCre-IRES-AP-kana in BAC-
GlyT2 
JH515/407 
JH0499/516 
1451 
1722 
Deletion of kanamycin cassette 
BAC-GAD65-tdTomato JH0381/525 2018 
BAC-GAD65-NCre-IRES-AP JH0309/518 1443 
BAC-GAD65-NCreERT2-IRES-AP JH0309/518 1443 
BAC-GlyT2-CCre-IRES-AP JH0309/516 1379 
BAC-GlyT2-ERT2CCre-IRES-AP JH0309/516 1379 
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 3.3.2.1 BAC-GAD65 clone 407K8 
To allow the transgene expression under control of the GAD65 promoter the target genes 
must be inserted in frame directly after the endogenous translational start signal, which is 
located at the end of Exon 1. The presence of the GAD65 exon 1 coding sequence within 
BAC 407K8 and the integrity of the BAC clone were verified by PCR as well as sequence 
analysis of exon 1 and selected areas in the 5’- and 3’-regions of the BAC (Tab. 8,Fig.) 
 
Tab. 8: Primers used for verification of wild-type 
BAC-GAD65 clone 407K8. 
Transcript Primer Product size (bp) 
Ex1 JH0381/382 1012 
5’A JH0373/374 365 
5’B JH0375/376 331 
5’C JH0385/386 635 
3’A JH0377/378 347 
3’B JH0379/380 348 
 
 
BAC 407K8 was modified using the target genes tdTomato, NCre-IRES-β-Gal and 
NCreERT2-IRES-β-Gal. 
The tdTomato open reading frame followed by SV40 polyadenylation signal was amplified 
from the expression vector pCMV-tdTomato (Clontech, Saint-Germain-en-Laye, France) and 
fused to a FRT-flanked neomycin cassette (pL451, NCI at Frederick, 
ncifrederick.cancer.gov). Additional, two sequences of 55 bp each homologous to the target 
site at the ATG initiation codon of exon 1 of the GAD65 gene, were fused to the 5’ and 3’ site 
of the tdTomato-FRT-neo-FRT fragment (Besser et al., 2015). See Fig. 5 C for the final 
targeting construct. 
The NCre and NCreERT2 open reading frames derived from pCMV-Tag2B-NCre and pCMV-
Tag2B-NCreERT2, respectively, (Hirrlinger et al., 2009a, 2009b) and were fused to an 
Internal ribosome entry site (IRES, pIRESneo3, Clontech, Saint-Germain-en-Laye, France) 
followed by the open reading frame for the β-Galactosidase (β-Gal, pWhere), the SV40 
polyadenylation sequence and the FRT-flanked neomycin cassette (pL451). The DNA 
construct was flanked by sequences homologous to the target site at the ATG initiation 
codon of exon 1 of the GAD65 gene, 670 bp at the 5’site and 1102 bp at the 3’ site of the 
DNA construct.  See Fig. 5 E for the final targeting constructs which were inserted into the 
BAC containing the GAD65 gene using homologous recombination as described above. The 
selection cassette for neomycin resistance was then removed by Flp-mediated 
recombination as described above and shown in Fig. 5.  
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Fig. 5: Strategy for the generation of GAD65-tdTomato mice as well as GAD65-NCre and 
GAD65-NCreERT2 mice expressing the proteins tdTomato, NCre or NCreERT2 under control of 
the GAD65 promoter in GABAergic neurons. A: Schematic representation of the BAC clone RPCI 
23-407K8 (208,325 bp in total) containing the mouse full-length gene GAD65. Locations of PCR 
products for BAC verification (5’A-C; 3’A-B; Ex1) are indicated. B: Structure of the wild type GAD65 
gene. The endogenous start codon is located within exon 1. PCR reaction with primers flanking exon 1 
(JH0381/382) results in a DNA fragment of 1012 bp. C: Structure of the targeting construct tdTomato-
kana which was inserted directly after the endogenous ATG using homologous recombination 
provoked by homology arms (HA) indicated. Note: The kanamycin resistance cassette is flanked by 
FRT sites (red triangles) D: Representation of the modified BAC containing the tdTomato gene after 
removal of the neomycin resistance cassette using Flp recombination. PCR using the same primers 
(Ex1) flanking exon 1 results in a product of 2746 bp in the modified BAC. E: Structure of the targeting 
constructs NCre-IRES-β-Gal-kana and NCreERT2-IRES-β-Gal-kana, which were used to generate 
BAC-GAD65-NCre-IRES-β-Gal and BAC-GAD65-NCreERT2-IRES-β-Gal, respectively, using the 
same procedure as described for tdTomato in panels A-D. Modified from Besser et al., 2015. 
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Modified BACs were verified using PCR and sequence analysis. PCR reaction was 
performed with the primers 381 and 382 that were placed within the BAC flanking the 
modification site around exon 1 (Ex1). The size of the resulting PCR products is shown in 
Tab. 9. PCR products were sequenced to verify sequence identity. Additional, the modified 
BACs were checked for integrity using PCR reaction of selected areas in the 5’- and 3’-
regions (Tab. 8). The successfully modified BACs were linearized using PI-SceI and purified 
using gel filtration. Purified linearized DNA was checked by pulse field gel electrophoresis 
and used for pronuclear injection in fertilized C57BL/6J oocytes.  
 
Tab. 9: PCR verification for successful modification of BAC-
GAD65 using the primers JH0381/382 flanking exon 1.  
BAC Product size (bp) 
BAC-GAD65 wild-type 1012 
BAC-GAD65-tdTomato-kana 4541 
BAC-GAD65-tdTomato 2746 
BAC-GAD65-NCre-IRES-LacZ-kana 7719 
BAC-GAD65-NCre-IRES-LacZ 5925 
BAC-GAD65-NCreERT2-IRES-LacZ-kana 8673 
BAC-GAD65-NCreERT2-IRES-LacZ 6879 
 
 
 3.3.2.2 BAC-GlyT2 clone 365E4 
BAC-GlyT2 clone 365E4 was modified as described in Zeilhofer et al., 2005. The gene GlyT2 
is expressed in two splice variants whereas the ATG of both transcripts is located within exon 
1, but at different positions. By replacing exon 2 of the endogenous GlyT2 gene the 
transgene expression can be controlled by the GlyT2 promoter.The presence of the GlyT2 
exon 2 coding sequence within BAC 365E4 as well as the integrity of the BAC clone were 
verified by PCR and sequence analysis of exon 2 and selected areas in the 5’- and 3’-
regions of the BAC (Fig. 6, Tab. 10) 
 
Tab. 10: Primers used for verification of BAC-
GlyT2 clone 365E4. 
Transcript Primer  Product size (bp) 
Ex2 JH0371/372 743 
5’A JH0365/366 384 
5’B JH0367/368 386 
5’C JH0383/384 686 
3’A JH0369/370 435 
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BAC 365E4 was modified using the targeting constructs CCre-IRES-AP and ERT2CCre-
IRES-AP. The CCre and ERT2CCre open reading frames derived from pCMV-Tag3B-CCre 
and pCMV-Tag3B-ERT2CCre, respectively. They were fused to an Internal ribosome entry 
site (IRES, pIRESneo3, Clontech) followed by the open reading frame for the human 
placental Alkaline Phosphatase (hAP, pZAP), the SV40 polyadenylation sequence and the 
FRT-flanked neomycin cassette. The DNA construct was flanked by sequences homologous 
to the target sites surround exon 2 of the GlyT2 gene, 703 bp at the 5’ site and 1055 bp at 
the 3’ site of the DNA construct.  See Fig. 6 C and E for the final targeting constructs which 
were inserted into the BAC containing the GlyT2 gene using homologous recombination. The 
selection cassette for neomycin resistance was then removed by Flp-mediated 
recombination as described above and shown in Fig. 6.  
Modified BACs were verified using PCR and sequence analysis. PCR reaction was 
performed with the primers 371 and 372 that were placed within the BAC flanking the 
modification site around exon 2. The size of the resulting PCR products is shown in Tab. 11. 
PCR products were sequenced to verify sequence identity. Additional, the modified BACs 
were checked for integrity using PCR reaction of selected areas in the 5’- and 3’-regions 
(Tab. 10). The successfully modified BACs were linearized using PI-SceI and purified using 
gel filtration. Purified linearized DNA was checked by pulse field gel electrophoresis and 
used for pronuclear injection in fertilized C57BL/6J oocytes. 
 
Tab. 11: PCR verification for successful modification of BAC-
GlyT2 using the primers JH0371/372 flanking exon 2.  
BAC Product size (bp) 
BAC-GlyT2 clone 362E4 743 
BAC-GlyT2-CCre-IRES-AP-kana 6028 
BAC-GlyT2-CCre-IRES-AP 4531 
BAC-GlyT2-ERT2CCre-IRES-AP-kana 6974 
BAC-GlyT2-ERT2CCre-IRES-AP 5515 
 
 
 4.3.3 Standard preparation of BAC-DNA 
For preparation of BAC-DNA the buffer solutions P1, P2 and N3 from the Qiagen Mini-
Preparation Kit were used, which routinely yielded 1 µg to 3 µg of DNA. 5 ml overnight 
culture (LB with cam) was centrifuged for 5 min at 5000 rpm, the supernatant discarded and 
the pellet resuspended in 250 ml buffer P1. Then 250 µl of buffer P2 were added and the mix 
incubated for 5 min at RT. Finally, 250 µl of buffer N3 were added and placed on ice for 5 
min. After the alkaline lysis of the bacteria the cell suspension was centrifuged two times at 
13200 rpm for 5 min. After each centrifugation step the supernatant was transferred to a new 
tube. For precipitation of DNA 750 µl Isopropanol were added and incubated on ice for 10  
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Fig. 6: Strategy for the generation of GlyT2-CCre and GlyT2-ERT2CCre mice expressing the 
proteins CCre or ERT2CCre under control of the GlyT2 promoter in glycinergic neurons. 
A: Schematic representation of the BAC clone RPCI 23-365E4 (179,407bp in total) containing the 
mouse full-length gene GlyT2. Locations of PCR products for BAC verification (5’A-C; 3’A; Ex2) are 
indicated. B: Structure of the wild type GlyT2 gene. The endogenous start codons of both splice 
variants of the GlyT2 gene are located within exon 1. PCR reaction with primers flanking exon 2 
(JH0371/372) results in a DNA fragment of 743 bp. C: Structure of the targeting construct CCre-IRES-
AP-kana which was inserted by replacing exon 2 using homologous recombination provoked by 
homology arms (HA) indicated. Note: The kanamycin resistance cassette is flanked by FRT sites (red 
triangles). D: Representation of the modified BAC containing the CCre-IRES-AP construct after 
removal of the neomycin resistance cassette using Flp recombination. PCR using the same primers 
(Ex2) flanking exon 2 results in a product of 4531 bp in the modified BAC. E: Structure of the targeting 
construct ERT2CCre-IRES-AP-kana, which was used to generate BAC-GlyT2-ERT2CCre-IRES-AP 
using the same procedure as described for CCre-IRES-AP in panels A-D.  
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min before centrifugation at 13200 for 10 min. The DNA pellet was washed with 70% ethanol 
and air dried for 10 to 20 min. The BAC-DNA was resolved in 50 to 30 µl TE buffer (10mM 
Tris pH7.5, 0.1mM EDTA, pH8) and stored at 4°C.  
 
 4.3.4 Preparation of BAC-DNA for oocyte injection 
For oocyte injection BAC-DNA was linearized with PI-SceI. Therefore 40 µg BAC-DNA were 
incubated with 10 units PI-SceI for 16 h at 37°C in 100 µl final volume. The enzyme was then 
inactivated for 15 min at 70 °C. 5 µl of the preparation were checked for linearization on a 0.5 
% agarose gel.  
Preparation of BAC DNA was performed using the NucleoBond BAC 100 Kit from Macherey-
Nagel according the manufacturer’s instructions. Purification of BAC-DNA was carried out 
using gel filtration. The filtration material, sepharose, functions as a molecular sieve. Large 
DNA molecules like BACs run faster through the sepharose column and elute earlier than 
small nucleotides and contaminations that infiltrate into the sepharose pores. For gel filtration 
one part of the Amersham CL-4B sepharose (Sigma-Aldrich) was diluted in three parts of 
injection buffer (10 mM Tris pH7.5, 0.1 mM EDTA pH 8.0, 100 mM NaCl). The tip of a 5-ml 
pipette was closed with a cotton plug. This pipette was used as the column. The sepharose 
was filled slowly into the column without bubbles. Then the packed column was equilibrated 
with 5 ml injection buffer for three times. The linearized BAC-DNA was diluted in injection 
buffer to obtain a final volume of 200 µl. 5 µl 0.25% bromophenol blue (Sigma-Aldrich) were 
added to the DNA solution. The column was then loaded with the BAC-DNA and layered with 
5 ml injection buffer. From this time-point 200 µl fractions were collected in 1.5 ml vials and 
DNA concentration of each fraction was checked with the NanoDrop2000. The fractions with 
the highest DNA content were verified using pulse field gel electrophoresis to proof the 
integrity, size and purity of the linearized BAC-DNA. Successful purified DNA was used for 
oocyte injection. 
 
 4.3.5 Oocyte injection 
The pronuclear injection of linearized BAC-DNA into fertilized C57BL/6J oocytes was 
performed by the transgene core facility of the Max-Planck-Institute for Experimental 
Medicine (Göttingen, Germany). Putative founder animals were checked for insertion of the 
transgene using PCR. All positive tested founder mice were transferred to the animal facility 
of the Medical Faculty of the University of Leipzig and cross-bred with C57/B6 wild-type mice 
to test the offspring for transgene expression. 
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4.4 Genotyping 
To discriminate transgenic mice from mice that do not carry the transgene a genotyping PCR 
with template DNA from tail biopsies was performed. 
 
 4.4.1 DNA preparation from tail biopsies 
For genotyping tail biopsies of mice at the age of three to four weeks were used. Therefore, 
0.2 cm of the tail tip was cut with a scissor and transferred into a 1.5 ml vial. The tail biopsies 
were stored at -20°C until DNA preparation.  
For preparation of genomic DNA 20 μl 10 x MGB buffer (Modified Gitschier Buffer, 670 mM 
Tris pH 8.8, 166 mM NH4SO4, 65 mM MgCl2 in A. dest.), 10 μl 10% Triton X-100 
(Applichem), 160 μl A. bidest und 10 μl 20 mg/ml proteinase K (Thermo Scientific) were 
added to the tail biopsy to obtain 200 µl final volume. The preparation was incubated at 55°C 
with 700 rpm shaking for 4 to 24 h until the tissue was completely lysed. After shortly mixing 
the probe was incubated for 30 min at 95°C in a water bath to inactivate the proteinase K. 
Finally, the preparation was centrifuged for 5 min at 13000 rpm and 1 µl of the DNA solution 
was used for genotyping PCR. 
 
 4.4.2 Genotyping PCR 
Genotyping PCR was performed in a final volume of 20 µl containing 10.8 μl A. bidest., 4 μl 
5 x Green GoTaq reaction buffer (Promega), 2 μl 2 mM dNTPs (Fermentas), 1 μl sense 
primer (5 μM, Tab. 12), 1 μl antisense primer (5 μM, Tab. 12), 0.2 μl GoTaq DNA polymerase 
(Promega) and 1 μl genomic DNA. 
 
Tab. 12: Primers for genotyping of all used transgenic 
mouse-lines as well as the expected product size for 
positive results. 
Mouse-line Primer Size [bp] 
TgN(GAD65-Ncre) JH511/JH414 698 
TgN(GAD65-NCreERT2) JH511/JH414 698 
TgN(GlyT2-CCre)  JH371/JH521 650 
TgN(GlyT2-ERT2CCre) JH371/JH131 862 
TgN(GAD65-tdTomato) JH402/JH420 259 
TgN(GlyT2-EGFP)  1957/JH372 800 
Ai14 reporter wild-type 3735/3737 500 
Ai14 reporter transgene JH526/JH527 550 
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DNA amplification was carried out using different PCR programs for each mouse-line 
(Tab. 13).  
 
Tab. 13: Optimized PCR programs for the genotyping of all used transgenic mouse-lines. 
Mouse-line Step Name Temperature Time 
TgN (GAD65-tdTomato) 1 Initial denaturation 95 °C 3 min 
 
2 Denaturation 95 °C 30 s 
3 Annealing and Elongation 64.6 °C 30 s 
Repeat of steps 2 and 3: 39 times 
4 Final extension 72 °C 5 min 
TgN (GlyT2-CCre) 1 Initial denaturation 95 °C 3 min 
 
2 Denaturation 95 °C 30 s 
3 Annealing and Elongation 66.4 °C 1 min 
Repeat of steps 2 and 3: 39 times 
4 Final extension 72 °C 5 min 
TgN (GlyT2-ERT2CCre) 1 Initial denaturation 95 °C 3 min 
 
2 Denaturation 95 °C 30 s 
3 Annealing  61,6°C 30 s 
4 Elongation 72°C 1 min 
Repeat of steps 2 to 4: 39 times 
5 Final extension 72 °C 5 min 
TgN (GAD65-NCre/NCreERT2) 1 Initial denaturation 95 °C 3 min 
 
2 Denaturation 95 °C 30 s 
3 Annealing 58°C 30 s 
4 Elongation 72°C 48 s 
Repeat of steps 2 to 4: 39 times 
5 Final extension 72 °C 5 min 
TgN (GlyT2-EGFP) 1 Initial denaturation 95 °C 3 min 
 
2 Denaturation 95 °C 30 s 
3 Annealing 63,5°C 30 s 
4 Elongation 72°C 48 s 
Repeat of steps 2 to 4: 39 times 
5 Final extension 72 °C 5 min 
Ai14 wild-type 1 Initial denaturation 95 °C 3 min 
 
2 Denaturation 95 °C 30 s 
3 Annealing 51,3°C 30 s 
4 Elongation 72°C 48 s 
Repeat of steps 2 to 4: 39 times 
5 Final extension 72 °C 5 min 
Ai14 transgene 1 Initial denaturation 95 °C 3 min 
 
2 Denaturation 95 °C 30 s 
3 Annealing and Elongation 64,6°C 50 s 
Repeat of steps 2 and 3: 39 times 
4 Final extension 72 °C 5 min 
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4.5 Application of tamoxifen 
The time-controlled activation of the Cre recombinase is achieved by application of tamoxifen 
(Sigma-Aldrich). To induce Cre recombination in adult mice (P30, 2.5 mo) a stock solution 
containing 10 mg/ml tamoxifen in sunflower oil/ethanol was prepared (ratio: 90 % sunflower 
oil and 10 % pure ethanol, J.T.Baker, Griesheim). 1 mg tamoxifen was injected 
intraperitoneal two times a day and on two following days. For mice at the age of P1 a stock 
solution of 20 mg/ml 4-OH-tamoxifen in ethanol was prepared. 100 µl 4-OH-tamoxifen stock 
solution were mixed with 500 µl sunflower oil. 10 µl (0.066 mg) per 1 g body weight were 
injected intraperitoneal once a day on two following days. 
 
4.6 Immunohistochemistry 
Adult mice were transcardially perfused with 4% paraformaldehyde in phosphate buffered 
saline (PBS: 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 0.15 mM KH2PO4, pH 7.4) under 
deep anesthesia with diethylether. Mice were decapitated, the brain removed from the scull 
and post-fixed for 24 h in the same fixative. Younger animals and embryos were immediately 
decapitated; the brains removed and fixed in 4 % PFA / PBS for 24 h. The preparation of 
embryos was performed by Prof. Dr. Swen Hülsmann as described in Rahman et al., 2015. 
40 µm thick sections were cut on a vibratome. Free-floating sagittal sections of the whole 
brain or coronal sections of the brainstem were incubated overnight (~16 h) at 4°C with the 
primary antibodies (Tab. 2) diluted in blocking reagent (2% normal goat serum / 0.2% Triton 
X-100 in PBS). Sections were washed three times for 5 min in PBS and incubated for 2 h at 
room temperature with the secondary antibodies (Tab. 2). For the antibodies rabbit anti-
GABA/ERα/β-Gal, mouse anti-GAD65/GAD67, rat anti-glycine and goat anti-ChAT staining 
protocols were optimized (Tab. 14). After washing with PBS, sections were incubated in PBS 
containing 1 µg/ml DAPI (Roth, Karlsruhe, Germany) for 5 min to stain cell nuclei. Finally, 
sections were mounted in Immu-Mount (Thermo Scientific). Confocal Images were acquired 
using a Zeiss LSM700 Axio Observer laser scanning microscope. For quantification, all 
experiments were performed on slices of three animals (n=3). Counting of cells was 
performed using Zeiss ZEN software on three sections per animal, of which three to four 
areas (320 µm x 320 µm or 640 µm x 640 µm) per section and brain region were imaged. For 
images of the whole brain an Axio Observer.Z1 microscope equipped with a motorized stage 
(Zeiss, Oberkochen, Germany) was used in the epifluorescence mode. 
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Tab. 14: Optimized staining protocols for selected antibodies. 
Antibody Blocking reagent Incubation of primary antibody 
Incubation of 
secondary 
antibody 
Rabbit anti-GABA 2% normal goat serum in PBS 4°C/16 h RT/2 h 
Rat anti-glycine 2% normal goat serum / 0.2% Triton X-100 in PBS RT/16 h RT/2 h 
Mouse anti-GAD65 
Mouse anti-GAD67 2% normal goat serum in PBS 4°C/16 h RT/2 h 
Rabbit anti-β-Gal 2% normal goat serum / 0.2% Triton X-100 in PBS 37°C/1.5h 37°C/1.5h 
Rabbit anti-Erα 2% normal goat serum / 0.2% Triton X-100 in PBS 37°C/1.5h 37°C/1.5h 
Goat anti-ChAT 2% normal donkey serum / 0.2% Triton X-100 in PBS 4°C/16 h RT/2 h 
 
 
4.7 Data processing and presentation 
Microscopic images were processed using Zeiss Axiovision software, Zeiss ZEN software, 
Image J and Adobe Photoshop CS2. Pie charts and bar graphs were generated using 
Microsoft Excel and Sigma Plot. All quantitative data in the text and shown in the figures are 
given as mean ± standard error of the mean or standard deviation. Final illustrations were 
arranged using Corel Draw X4 Graphic. 
 
 
Results____________________________________________________________________ 
34 
 
5. Results 
5.1 Identification of the Pre-Bötzinger Complex in TgN(GlyT2-EGFP) mice 
Neurons of the Pre-Bötzinger Complex are located around the cholinergic motoneurons of 
the Nucleus ambiguus (N. amb.) in the ventral lateral medulla (Fig. 7 A). In coronal slices of 
the brainstem of TgN(GlyT2-EGFP) mice (Tab. 3) the N. amb. can be identified as a “dark 
spot” in between the dense net of green glycinergic neurons of the PBC (Fig. 7 B, C). Using 
immunohistochemical staining with an antibody raised against Choline-Acetyltransferase 
(ChAT) as a marker for cholinergic neurons the N. amb. as well as the glycinergic neurons of 
the PBC are clearly visible in fixed brainstem slices (Fig. 7 B). No cholinergic cells are 
detectable in the negative control showing the specificity of the staining procedure (Fig. 7 C). 
 
 
Fig.7: Location of the PBC in the medulla of TgN(GlyT2-EGFP) mice. A: Schematic representation 
of the murine ventral medulla with the N. ambiguous (N. amb.) and the Pre-Bötzinger Complex (PBC, 
red circle). The right hand side represents a Nissl staining of the same region (modified from “Atlas of 
the Developing Mouse Brain”, Paxinos et al. 2007). B: Immunohistochemical staining with an antibody 
raised against ChAT shows the cholinergic neurons of the N. ambiguous (red) within the glycinergic 
neurons (green) of the PBC of TgN(GlyT2-EGFP) mice. C: Negative control by immunohistochemical 
staining without the primary antibody against CHAT reveals no unspecific binding of the secondary 
antibody on slices of TgN(GlyT2-EGFP). The scale bar represents 150 µm and applies to B and C. 
 
 
5.2 Identification of GABA- and glycine cotransmitting neurons in the PBC of 
TgN(GlyT2-EGFP) mice  
Neurons that corelease two or more transmitters were recently found in several areas of the 
brain (Trudeau and Gutiérrez, 2007). The cotransmission of GABA and glycine was 
described for the spinal cord (Ishibashi et al., 2013; Jonas et al., 1998; Polina et al., 2007), 
the cerebellum (Dugué et al., 2005; Dumoulin et al., 2001) as well as different regions of the 
brainstem, e. g the auditory nucleus (Lu et al., 2008). So far, no information about the 
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presence and relevance of GgC neurons2 is available for the respiratory centre. As inhibitory 
interneurons of the PBC were found to release either glycine or GABA (Ramirez and Richter, 
1996; VanDam et al., 2008) it was hypothesized that GgC neurons also exist in the PBC.  
The existence of GgC neurons was investigated with different approaches. In a first step 
coexpression of mRNAs characteristic for GgC neurons was analysed by a multiplex nested 
single-cell (sc) RT-PCR. For this approach cytosol of EGFP-expressing neurons in slices of 
TgN(GlyT2-EGFP) mice was harvested (n = 50 cells, Fig. 8 A) and analysed for the 
expression of the mRNAs of GlyT2, GAD65, GAD67, GABA transporter 1 (GAT1) as well as 
β-actin as control for successful harvesting of cytosol (Fig. 8 B, C). 
 
 
Fig. 8: Single-cell RT-PCR shows a significant number of glycinergic neurons expressing 
mRNA for GABAergic neuronal markers. A: Harvesting of cytosol from an EGFP-expressing cell in 
an acutely isolated brain slice of TgN(GlyT2-EGFP) mice. After attachment of the patch pipette to a 
cell (1), suction is applied. The green fluorescent cytosol is visible within the pipette (2). The scale bar 
represents 20 µm. B: Examples of scRT-PCR results of six cells show the heterogeneity of the 
expression pattern. M: DNA size marker. Bands correspond to 500 (bright), 400, 300, 200 and 100 bp 
from top to bottom. C: Quantification of the results of 50 cells (modified from Rahman et al., 2013).  
                                                          
2
 GgC neuron: Abbreviation for GABA and glycine cotransmitting neuron. 
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32 EGFP-positive neurons (64%) expressed the mRNA for at least one GABAergic neuronal 
marker (GAD65, GAD67, and/or GAT1). Out of these 32 cells, 23 cells (46%) also contained 
mRNA for GlyT2 whereas the detection of GlyT2 mRNA failed in 9 cells (18%). Only GlyT2 
mRNA but no GABA marker was found in a single GlyT2-EGFP neuron (2%, Fig. 8 C). In 18 
cells (34%), only β-actin was detected (Fig. 8 C). These data imply that a high proportion of 
inhibitory neurons in the murine PBC contain the genetic composition for a dual GABAergic 
and glycinergic phenotype at the ages of P1 to P10 (data published in Rahman et al., 2013).  
 
In a second step the existence of GgC neurons was verified using immunohistochemistry 
with an antibody raised against the transmitter GABA on slices of TgN(GlyT2-EGFP) mice to 
simultaneously identify glycinergic cells by EGFP expression. Anti-GABA staining on 
brainstem slices of 10-day-old mice revealed three inhibitory neuron populations in the PBC 
(Fig. 9 A): pure GABAergic neurons (red), pure glycinergic neurons (green) as well as 
glycinergic neurons containing the transmitter GABA (yellow). In the negative control 
(Fig. 9 B) lacking the primary antibody no red GABAergic cells are detectable demonstrating 
no unspecific binding of the secondary antibody. These data show the existence of 
glycinergic neurons containing the transmitter GABA which implies strong evidence that 
these neurons are GgC neurons. 
 
5.3 Generation of a transgenic mouse-line for visualization of GgC neurons in living 
tissue preparations 
The identification of GABA- and glycine cotransmitting neurons in living slice preparations for 
electrophysiological recordings is crucial to analyse the corelease of GABA and glycine from 
these neurons as well as the contribution of this cell population to the respiratory rhythm 
generation. To analyse GgC neurons in-vivo or living brainstem preparations these neurons 
must be visible not only in fixed tissue and without additional staining procedures which 
necessitates the generation of a novel transgenic mouse-line. Therefore, a new BAC 
transgenic mouse-line, TgN(GAD65-tdTomato), was generated, which expresses the red 
fluorescent protein tdTomato under the control of the GAD65 promotor, which is a reliable 
marker for GABAergic neurons. This mouse-line was crossbred to TgN(GlyT2-EGFP) mice 
(Zeilhofer et al., 2005) that express EGFP in glycinergic cells. In double-transgenic mice 
(named “Cofluor” mice), GABAergic neurons show the red fluorescence of the tdTomato 
protein, glycinergic neurons show the green fluorescence of EGFP and cotransmitting 
neurons can be detected easily by the expression of both fluorescent proteins. 
 
                                                                                                                                      Results 
37 
 
 
Fig. 9: Immunohistochemical identification of GgC neurons in the PBC of TgN(GlyT2-EGFP) 
mice. A: Immunohistochemical staining with an antibody raised against GABA reveals pure 
GABAergic neurons (red), pure glycinergic neurons (green) and double-positive neurons (yellow) that 
were identified as GgC neurons. Arrows highlight examples of cells expressing only GABA (red), only 
EGFP (green) or both, GABA and EGFP (yellow) B: The same staining procedure but without the 
primary antibody against GABA shows no unspecific binding of the secondary antibody on slices of 
TgN(GlyT2-EGFP). The scale bar represents 75 µm and applies to all panels. 
 
 
5.3.1 Establishment and expression pattern of TgN(GAD65-tdTomato) mice 
To stain GABAergic interneurons by a red fluorescent protein, a mouse-line expressing 
tdTomato under control of the GAD65-gene was generated using transgenesis based on 
bacterial artificial chromosomes (BACs). The start codon of the fluorescent protein was 
inserted at the exact position of the start codon of the endogenous Gad65 gene within exon 1 
to express tdTomato as similar as possible to the endogenous GAD65 gene. Successful 
modification as well as integrity of the BAC-construct was verified by PCR (Tab. 9) and 
sequencing (data not shown). 
After microinjection of the BAC-GAD65-tdTomato construct into mouse oocytes, 11 
transgenic founder mice were born. Out of these 11 lines, seven lines showed tdTomato 
fluorescence to a different extent but only in the olfactory bulb (data not shown) and only one 
mouse line showed bright expression of tdTomato in all expected regions of the brain. This 
line was further analysed in detail.  
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Expression of tdTomato was analysed at different developmental stages (P1, P3, P10 and 
2.5 months; Fig. 10). The strongest fluorescence was observed in the olfactory bulb and the 
striatum, i.e. regions with a high number of GABAergic neurons, in all developmental stages 
(Fig. 10). Many tdTomato-expressing neurons were detected in the cortex within all cortical 
layers (Fig. 10 and Fig. 11 B) as well as in the hippocampus (Fig. 10 and Fig. 11 C), the area 
of the Superior Colliculus, Inferior Colliculus and midbrain. Numerous cells in the brainstem 
showed bright fluorescence in younger transgenic mice (P3 and P10), whereas in adult mice, 
a dense net of neurites was observed in addition to neuronal somata (Fig. 11 D; Besser et 
al., 2015).  
 
 
Fig. 10: Overall expression pattern of tdTomato in GAD65-tdTomato mice at different 
developmental stages. In sagittal brain slices, high tdTomato expression was found in the olfactory 
bulb and striatum as well as in the cortex, hippocampus, brainstem and substantia nigra in all 
analysed developmental stages (A: P1, B: P3, C: P10, D: 2.5 months). Fluorescence intensity of cells 
varied highly within one brain region and between different areas of the brain as well as different 
stages of development. The scale bars represent 500 µm. Figure modified from Besser et al., 2015. 
 
 
At higher magnification, tdTomato fluorescence was observed in dendrites, somata and 
axons of neurons, indicating that the fluorescent protein is distributed throughout the cells. 
The intensity of tdTomato fluorescence reflects the amount of tdTomato expression and 
showed a wide variety from rather dark to very bright cells in all brain regions (Fig. 11), 
consistent with the known variability in expression levels of the endogenous GAD65 gene 
(Dupuy and Houser, 1996; Feldblum et al., 1993). 
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Fig. 11: TdTomato expression in various brain regions of GAD65-tdTomato mice at different 
developmental stages (P1; P3; P10; 2.5 months). A: Olfactory bulb; B: Cortex; C: Hippocampus; D: 
Brainstem; E: Cerebellum. TdTomato is expressed in many GABAergic neurons within these brain 
regions and is visible in somata, dendrites, as well as axons. The scale bar represents 50 µm and 
applies to all panels. Figure modified from Besser et al., 2015. 
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5.3.2 Verification of TgN (GAD65-tdTomato) 
To verify tdTomato-expressing neurons as GABAergic, GAD65-positive neurons, 
coexpression of tdTomato and endogenous GAD65-protein was investigated using 
immunohistochemistry (Fig. 12 A-D) and quantified for cortex (Ctx, medial prefrontal and 
somatosensory cortex, all layers), hippocampus (HC, Gyrus dentatus and CA1-3), Pre-
Bötzinger Complex (PBC) and olfactory bulb (OB, Glomerular layer, External plexiform layer, 
Mitral cell layer, Internal plexiform layer, Granule cell layer) of adult transgenic mice by 
counting cells expressing only tdTomato, only endogenous GAD65-protein as well as 
neurons double-positive for tdTomato and GAD65 (Fig. 12 E).  
 
 
 
Fig. 12: Immunohistochemical verification of tdTomato-expressing cells as GAD65-positive 
interneurons in GAD65-tdTomato mice. An antibody raised against GAD65 (green) was used to 
identify tdTomato-positive cells as GABAergic neurons in 2.5 month old mice. A: Cortex; B: 
Hippocampus; C: Brainstem; D: Olfactory bulb. All nuclei were stained with DAPI (blue). Arrows 
highlight examples of cells expressing both tdTomato and GAD65. The scale bar represents 50 µm 
and applies to all panels. E: Quantification of cells expressing tdTomato in the absence of GAD65-
immunoreactivity (red); GAD65-positive cells lacking tdTomato fluorescence (green) as well as 
neurons simultaneously expressing tdTomato and endogenous GAD65 (yellow). While 10% to 20% of 
GAD65 expressing neurons do not express tdTomato, almost all cells showing tdTomato fluorescence 
are indeed GAD65-positive GABAergic neurons (modified from Besser et al., 2015).  
 
 
Within these brain regions, a high percentage of neurons was double-positive for tdTomato 
fluorescence and GAD65 immunostaining (Ctx: 89.9 ± 3.7%; HC: 88.6 ± 1.8%; PBC: 84.2 ± 
2.2%; OB: 81 ± 0.7%; all mean ± SD; n = 3 mice; total number of cells counted: Ctx: 4788; 
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HC: 1593; PBC: 949; OB: 2021). Only a small proportion of cells expressed GAD65 protein 
without tdTomato fluorescence (Ctx: 9.4 ± 3.6%; HC: 10.0 ± 2.2%; PBC: 15.0% ± 1.7%; OB: 
18.9 ± 0.8%). Most importantly, only a very small number of cells showed tdTomato 
expression in the absence of endogenous GAD65-protein (Ctx: 0.7 ± 0.2%; HC: 1.4 ± 0.8%; 
PBC: 0.8% ± 0.6%; OB: 0.1 ± 0.2%). These data imply that cells expressing tdTomato are 
indeed GABAergic neurons, although not all GABAergic cells are labelled by tdTomato 
fluorescence (Fig. 12 E; Besser et al., 2015). 
 
5.3.3 Generation of the double-transgenic mouse-line Cofluor 
To allow for colabelling of glycinergic and GABAergic neurons as well as the identification of 
GgC neurons in living slice preparations of the respiratory centre the new established 
mouse-line TgN(GAD65-tdTomato) was crossbred to TgN(GlyT2-EGFP). In this double-
transgenic mouse-line (“Cofluor”), GABAergic neurons showed the red fluorescence from 
tdTomato protein (Fig. 13, red arrows) and glycinergic cells carried the green fluorescence 
from EGFP (Fig. 13, green arrows). Both neuron populations can be clearly distinguished by 
their fluorescence spectra with confocal (Fig. 13), epifluorescence and 2-photon-microscopy 
(Besser et al., 2015).  
Furthermore, neurons expressing EGFP and tdTomato are present in the PBC of 10-day-old 
Cofluor-mice (Fig. 13, yellow cells, highlighted with yellow arrows). As the expression of 
GlyT2 and GAD65 are reliable markers for glycinergic and GABAergic cells, respectively, 
these double-positive neurons are GgC neurons with high probability. 
 
5.4 Neurons of the PBC show development-dependent differences in transmitter 
composition 
Young inhibitory pathways are predominantly GABAergic and switch to glycinergic 
transmission during development in brainstem auditory nuclei (Awatramani et al., 2005; 
Kotak et al., 1998; Nabekura et al., 2004). To investigate whether inhibitory neurons of the 
PBC also show differences in transmitter composition during maturation of the brain 
GABAergic, glycinergic and GgC neurons were quantified by counting tdTomato-expressing, 
EGFP-expressing and double-positive neurons in Cofluor mice before birth at E15.5 and 
E17.5 as well as after birth at P1, P4, P8, P10, P14, P30 and 2.5 mo (Fig. 14, all mean ± SD; 
n = 3 mice per age). Quantification was performed on three different areas of the PBC per 
age. No differences in the relative cell number of GABAergic, glycinergic and GgC neurons 
between these areas were found (data not shown). Therefore, data were pooled from all 
three areas. 
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Fig. 13: Generation of the Cofluor mouse-line. A: Crossbreeding of TgN(GlyT2-EGFP) with 
TgN(GAD65-tdTomato) to establish the double-transgenic mouse-line Cofluor. B: In the PBC of this 
transgenic mouse-line GABAergic neurons are labelled with the red fluorescence (red arrows) 
whereas glycinergic cells show the green fluorescence (green arrows). The yellow cells express both, 
EGFP and tdTomato (yellow arrows), combining properties of glycinergic and GABAergic neurons. 
These neurons were identified as GgC neurons. Shown are images of the PBC of a 10 day old mouse. 
The scale bar represents 75 µm and applies to all panels. 
 
 
In the early development from E15.5 to P1 the number of cotransmitting neurons decreased 
from 64% (± 2.3%) to 52.9% (± 3.5%), whereas the percentage of GABAergic cells increased 
from 16.5% (± 1.9%) to 28.1% (± 1.5%) but the proportion of glycinergic neurons was 
constant at 19% (E15.5: 19.5 ± 0.84%; E17.5: 19.2 ± 0.44%; P1: 19 ± 2.9%). From P1 to P10 
the percentage of double-positive cells decreased further to 16.9% (± 2.4%) whereas now 
the number of glycinergic neurons increased strongly from 19% to 42.3% (± 2.4%). The 
number of GABAergic neurons increased to 40% (± 2.4%) at P10 and showed a constant 
proportion of about 38% in further development (P14 to 2.5 mo). Similar results were 
obtained for glycinergic and double-positive neurons that showed a constant number from 
P14 to 2.5 mo of about 50% and 12.5%, respectively. These results imply a shift in 
transmitter composition from a dual GABA/glycinergic phenotype at embryonal day 15.5 to 
pure GABAergic or glycinergic transmission in adult mice of 2.5 mo (Fig. 14 J).  
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Fig. 14: Developmental change of the percentage of GABAergic (red), glycinergic (green) and 
GgC neurons (yellow) in the PBC of Cofluor mice. A-I: Representative images of the PBC at the 
ages E15.5 (A), E17.5 (B), P1 (C), P4 (D), P8 (E), P10 (F), P14 (G), P30 (H) and 2.5 mo (I). The scale 
bar represents 75 µm and applies to all panels. J: Quantification (n = 3 mice; 1142 to 2565 cells were 
counted in total per age) of GABAergic tdTomato expressing neurons, glycinergic EGFP expressing 
cells and double-positive cells reveals a developmental shift from a dual GABA/glycine transmission in 
the early development to pure GABAergic or glycinergic transmission in the mature PBC. 
 
 
The decrease in the relative amount of GgC neurons as well as the increase of GABAergic 
and glycinergic neurons (Fig. 14 J) could be caused either by differentiation of GgC neurons 
to GABAergic or glycinergic neurons or by selective cell death of GgC neurons. Indeed, cell 
density of neurons decreased during development (Fig. 14 A-I; Fig. 15 C). However, during 
development also the size of the brain increases resulting in a decrease of cell density even 
if no change in the absolute cell number would occur. Therefore, to calculate the total 
number of cells at different ages, the change in size of the brain (and therefore the change in 
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PBC size assuming that the PBC changes similarly as the whole brain) was estimated by 
measuring the area of the whole brain slice (Fig. 15 A, red line) or the N. amb. (Fig. 15 A, 
blue line; the area of the PBC could not reliably be measured directly as it is very difficult to 
exactly define the borders of the PBC). As expected, the area of the slices (Fig. 15 B, red 
bars) as well as the area of the N. amb. (Fig. 15 B, blue bars) increases with the growth of 
the mouse brain from E15.5 to 2.5 month. However, the total cell numbers estimated from 
the cell density as well as the area either of the whole brainstem slices (Fig. 15 D, red bars) 
or the N. amb. (Fig. 15 D, blue bars) showed no significant differences during development 
(Fig. 15 D) indicating that the number of inhibitory neurons in the PBC remains rather 
constant and cell death does not substantially contribute to the observed changes in the 
relative amounts of GgC., GABAergic and glycinergic neurons. 
 
5.5 The fate of GgC neurons in the PBC 
The previous results showed a decrease of the relative number of GgC neurons from the 
early development to the adult stage whereas the percentage of GABAergic and glycinergic 
neurons increased. This raises the question whether GgC neurons differentiate to pure 
GABAergic and/or glycinergic neurons, or whether GgC cells maybe died in the early 
development whereas GABAergic as well as glycinergic neurons proliferated. An early 
postnatal programmed cell death is for instance observed in other brain regions e.g. the 
cerebral cortex (Gould and McEwen, 1993; Kole et al., 2013; Nikolić et al., 2013; Yamaguchi 
and Miura, 2015). 
To investigate the fate of GgC neurons it is necessary to stain these cells irreversibly at a 
specific time-point in development. This allows the identification these neurons at a later 
time-point even if these neurons are not GgC neurons anymore. A general strategy used for 
such an irreversible labelling of cells is the Cre-LoxP based fate mapping approach 
(Bockamp et al., 2008; Gu et al., 1993; Lewandoski, 2001; Tsien et al., 1996). Here, 
irreversible staining of GgC neurons was achieved by using the tamoxifen-inducible Split-
CreERT2 system (Hirrlinger et al., 2009b; for details see introduction 1.5). Two novel mouse-
lines were established using transgenesis based on BACs. The first line expresses 
NCreERT2 in GABAergic neurons under control of the GAD65 promoter (TgN[GAD65-
NCreERT2]). In the second mouse-line ERT2CCre expression is driven by the GlyT2 
promoter in glycinergic neurons (TgN[GlyT2-ERT2CCre], Fig. 16 A). Crossbreeding of  
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Fig. 15: The total number of inhibitory neurons does not change within the PBC during 
development. A: Coronal brainstem slice of a Cofluor mouse (here at the age of P30). Inhibitory 
neurons were quantified in 3 sections of the PBC (white line) for 3 slices per mouse and 3 mice per 
age (n = 3). The red line marks the area of the whole slice; the blue line highlights the area of the N. 
amb. The scale bar represents 500 µm. B: The area of the coronal slices (red bars, left y-axis) as well 
as the N. amb. (blue bars, right y-axis) increases during development from E15.5 to 2.5 mo whereas 
the cell density of inhibitory neurons in the PBC decreases (C). Data of E15.5 to P30 were compared 
to 2.5 mo. *p ≤ 0.01 vs. 2.5 mo. D: The total number of inhibitory neurons calculated from the cell 
density (C) and the area of the whole coronal slices (red bars, left y-axis) and the N. amb. (blue bars, 
right y- axis) shows no significant differences during development. 
 
 
TgN(GAD65-NCreERT2) to TgN(GlyT2-ERT2CCre) and the Ai14 reporter line3 (Madisen et 
al., 2010; Fig. 16 A) generates triple transgenic mice, which are referred to as “COTRIND 
mice” (cotransmission with inducible recombination). In COTRIND mice only GgC neurons 
coexpress NCreERT2 and ERT2CCre which results in functional complementation of both 
Cre parts after tamoxifen application, recombination of the reporter DNA construct and finally 
expression of RFP exclusively in GgC neurons (Fig. 16 B). 
In this chapter the generation and verification of TgN(GAD65-NCreERT2) and TgN(GlyT2-
ERT2CCre) is described followed by the establishment of the mouse-line COTRIND to 
                                                          
3
 The mouse-line Ai14 is described to express tdTomato after Cre-mediated recombination. To avoid a mix up of 
COTRIND mice with TgN(GAD65-tdTomato)-mice, in this work the reporter protein for irreversible staining of GgC 
neurons is denominated RFP.  
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achieve an irreversible staining of GgC neurons in the PBC. Finally, the fate of RFP-labelled 
GgC neurons was investigated. 
 
 
 
Fig. 16   : Generation of the triple-transgenic mouse-line COTRIND and principle of Split-
CreERT2-mediated RFP expression in GgC neurons. A: In TgN(GAD65-NCreERT2) mice only 
GABAergic neurons express NCreERT2; in TgN(GlyT2-ERT2CCre) only glycinergic neurons express 
ERT2CCre. The reporter line Ai14 harbours the reporter construct consisting of a loxP-flanked stop 
sequence followed by the open reading frame for RFP. Crossbreeding of TgN(GAD65-NCreERT2) 
with TgN(GlyT2-ERT2CCre) and the reporter line resulted in triple-transgenic offspring, the COTRIND 
mice. B: In COTRIND mice GgC neurons coexpress NCreERT2 and ERT2CCre. After the application 
of tamoxifen the Cre parts complement functionally leading to DNA recombination and finally to RFP 
expression in GgC neurons. 
 
 
5.5.1 Generation and verification of TgN(GAD65-NCreERT2) 
After microinjection of the BAC-GAD65-NCreERT2-IRES-β-Gal construct into mouse 
oocytes, 10 transgenic founder mice were born. Expression of NCreERT2 was analysed by 
immunohistochemical staining with an antibody raised against β-Gal which was used as a 
reporter for the verification of the transgene expression. Only one mouse-line showed the 
expected staining pattern for β-Gal in the olfactory bulb, striatum, cortex (data not shown) 
and brainstem (Fig. 17 A). As expected the staining was detected within the nuclei 
(Fig. 17 A) due to a nucleus localization sequence within the open reading frame of β-Gal. To 
exclude an unspecific binding of the β-Gal antibody in fixed mouse brainstem preparations 
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the staining was also carried out on slices of wild-type mice (Fig. 17 B). In these mice no 
immunoreactivity against β-Gal was detectable.   
 
 
Fig. 17: Screening of TgN(GAD65-NCreERT2) founder mice for transgene expression in the 
PBC using an antibody raised against β-Galactosidase (β-Gal). A: Expression of β-Gal in 
transgenic founder mice was detected within the nuclei due to a nucleus localization sequence within 
the coding sequence of β-Gal. B: In wild-type (wt) mice no immunoreaction against β-Gal was 
detectable. The scale bar represents 20 µm and applies to all panels. 
 
 
This mouse line was analysed in detail and β-Gal expression was verified in GABAergic 
neurons (Fig. 18). To verify NCre/β-Gal-expressing neurons as GABAergic, GAD65-positive 
neurons, coexpression of β-Gal and endogenous GAD65-protein was investigated using 
immunohistochemistry (Fig. 18). To exclude unspecific binding of the secondary antibodies 
negative controls were performed using the same staining protocol but lacking the primary 
antibodies against GAD65 (Fig. 18 B) or β-Gal (Fig. 18 C). No cross-reaction between the 
secondary antibodies and the brain tissue was detectable (Fig. 18 B, C). Images were 
quantified for the PBC of adult transgenic mice by counting cells expressing only β-Gal, only 
endogenous GAD65-protein as well as neurons double-positive for β-Gal and GAD65 
(Fig. 18 D, mean ± SD; n = 3 mice). In the PBC 59.8% (± 2.2%) neurons were double-
positive for β-Gal and GAD65 immunoreaction whereas 37.0% (± 3.4%) of cells showed 
GAD65 immunoreaction without β-Gal staining. 3.2% (± 1.2%) expressed β-Gal in the 
absence of detectable levels of endogenous GAD65-protein (total number of counted 
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cells: 476, set as 100%). These data imply that the transgene consisting of NCreERT2 and 
β-Gal is not expressed in all GABAergic cells but neurons expressing NCreERT2/β-Gal are 
indeed GABAergic neurons (Fig. 18 D).  
 
 
Fig. 18: Immunohistochemical verification of NCreERT2/β-Gal-expressing cells as GAD65-
positive interneurons in GAD65-NCreERT2 mice. A: An antibody raised against β-Gal was used to 
identify NCreERT2/β-Gal expressing neurons (red). To verify these neurons as GABAergic neurons in 
2.5 month old mice a costaining with an antibody raised against GAD65 (green) was performed. 
Arrows highlight examples of cells expressing both NCreERT2/β-Gal and GAD65. B, C: Negative 
controls lacking the primary antibody against GAD65 (B) and β-Gal (C) were performed in parallel and 
showed no cross-reaction of the secondary antibodies with the tissue. The scale bar represents 50 µm 
and applies to all panels. D: Quantification of cells expressing NCreERT2/β-Gal in the absence of 
GAD65-immunoreactivity (red); GAD65-positive cells lacking NCreERT2/β-Gal fluorescence (green) 
as well as neurons simultaneously expressing NCreERT2/β-Gal and endogenous GAD65 (yellow). 
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5.5.2 Generation and verification of TgN(GlyT2-ERT2CCre) 
After microinjection of the BAC-GlyT2-ERT2CCre-IRES-AP construct into mouse oocytes, 
two transgenic founder mice were born. Immunohistochemical staining against the human 
estradiol receptor ERT2 was performed to analyse ERT2CCre expression in transgenic 
founder mice (the antibody does not cross-react with the endogenous mouse estradiol 
receptor; Hirrlinger et al., 2006). The two mouse-lines showed a staining pattern for ERT2 as 
expected in the brainstem (Fig. 19 A). The staining was detected within the nuclei (Fig. 19 A) 
due to a nucleus localization sequence within the coding sequence of ERT2CCre. To 
exclude an unspecific binding of the antibody in fixed mouse brainstem preparations the 
staining was also performed on slices of wild-type mice (Fig. 19 B), which showed no 
immunoreaction against ERT2.  
 
 
Fig. 19: Screening of TgN(GlyT2-ERT2CCre) founder mice for transgene expression in the PBC 
using an antibody raised against the human estradiol receptor ERT2. A: Expression of 
ERT2CCre in transgenic founder mice was detected within the nuclei due to a nucleus localization 
sequence within the open reading frame of ERT2CCre. B: In wild-type (wt) mice no immunoreaction 
against ERT2CCre was detectable. The scale bar represents 20 µm and applies to all panels. 
 
 
Out of the two mouse lines, one was analysed in detail and ERT2CCre expression was 
verified in glycinergic neurons (Fig. 20). Coexpression of ERT2CCre and endogenous 
glycine was analysed using immunohistochemistry. The same staining protocol but lacking 
the primary antibodies against glycine (Fig. 20 B) and ERT2 (Fig. 20 C) was performed as 
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negative controls to exclude unspecific binding of the secondary antibodies. No cross-
reaction between the secondary antibodies and the brain tissue was detectable 
(Fig. 20 B, C). Images were quantified for the PBC of adult transgenic mice by counting cells 
expressing only ERT2CCre, only glycine as well as neurons double-positive for ERT2CCre 
and glycine (Fig. 20 D, all mean ± SD; n = 3 mice). In the PBC 78.4% (± 1.9%) neurons were 
double-positive for ERT2 protein and glycine immunostaining whereas 18.3% (± 2.5%) of 
cells showed glycine immunoreactivity without ERT2 staining. 3.4% (± 1.4%) expressed 
ERT2 in the absence of detectable levels of endogenous glycine (total number of counted 
cells: 1258 = 100%). These data indicate that neurons expressing ERT2CCre are indeed 
glycinergic neurons although ERT2CCre is not expressed in all glycinergic cells (Fig. 20 D).  
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5.5.3 Irreversible staining of GgC neurons in transgenic mice 
To mark GgC neurons irreversibly in transgenic mice TgN(GAD65-NCreERT2) and 
TgN(GlyT2-ERT2CCre) were crossbred to each other and additional to the RFP reporter line 
Ai14 (Fig. 16 A). The resulting triple-transgenic COTRIND mouse-line expresses NCreERT2 
in GABAergic neurons and ERT2CCre in glycinergic neurons. In GgC neurons both Cre parts 
are coexpressed in one cell. But only after application of tamoxifen NCreERT2 and 
ERT2CCre can complement functionally and induce DNA recombination resulting in RFP 
expression exclusively in GgC neurons (Fig. 21 A).  
COTRIND mice that received tamoxifen injections at P1/P2 and were analysed at 2.5 month 
of age showed many RFP-expressing neurons in coronal slices of the whole brainstem 
(Fig. 21 B) and in the PBC (Fig. 21 C). As these neurons were irreversibly marked by RFP 
fluorescence at P1/P2, they were GgC neurons in early development at P1/P2. Importantly, 
these neurons still exist in 2.5 mo old mice demonstrating that – once irreversibly stained – 
GgC neurons from P1/P2 can also be identified in adult mice by the RFP fluorescence even 
if they are no GgC neurons anymore.  
This experiment shows for the first time that the complementation of NCreERT2 and 
ERT2CCre followed by Cre-mediated reporter expression after induction with tamoxifen 
works not only in cell culture (Hirrlinger et al., 2009b) but also in transgenic mice. By the use 
of the Split-CreERT2 system GgC neurons can be stained irreversibly at the time-point of 
tamoxifen injection. 
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← Fig. 20: Immunohistochemical verification of ERT2CCre-expressing cells as glycinergic 
interneurons in GlyT2-ERT2CCre mice. A: An antibody raised against ERT2 was used to identify 
ERT2CCre-expressing neurons (red). To verify ERT2CCre-expressing cells as glycinergic neurons in 
2.5 month old mice a costaining with an antibody raised against glycine (green) was performed. 
Arrows highlight examples of cells expressing both ERT2 and glycine. B, C: To exclude unspecific 
binding of the secondary antibodies negative controls lacking the primary antibody against glycine (B) 
and ERα (C) were performed in parallel and showed no cross-reaction of the secondary antibodies 
with the tissue. The scale bar represents 50 µm and applies to all panels. D: Quantification of cells 
expressing ERT2CCre in the absence of glycine immunoreactivity (red); glycinergic cells lacking 
ERT2CCre staining (green) as well as neurons simultaneously expressing ERT2CCre and 
endogenous glycine (yellow). While 18.3% of glycinergic neurons do not express ERT2CCre, almost 
all cells showing ERT2 immunoreactivity are indeed glycinergic neurons.  
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Fig. 21: Irreversible staining of GgC neurons using the Split-CreERT2 system in transgenic 
mice. A: In COTRIND mice GgC neurons coexpress NCreERT2 and ERT2CCre. Both Cre parts are 
inactive. After the application of tamoxifen NCreERT2 and ERT2CCre can complement and form an 
active enzyme which binds the loxP sites and leads to DNA recombination resulting in RFP expression 
(see also Fig. 16 for details on the underlying three mouse lines). B: Coronal slice of the whole 
brainstem of a COTRIND mouse that received tamoxifen at P1/P2 and was analysed at 2.5 mo of age. 
Neurons that show the RFP fluorescence were GgC neurons at P1/P2. The PBC can be identified as 
the region around the N. ambiguus (“dark spots”, N. amb.). The scale bar represents 1 mm. C: Higher 
magnification of the PBC in COTRIND mice revealed many RFP-expressing neurons in the 2.5 mo old 
COTRIND mouse after tamoxifen injection at P1/P2. The scale bar represents 100 µm. 
 
 
 
 
 
 
                                                                                                                                      Results 
53 
 
Furthermore, the SplitCreERT2 system shows no leakage in transgenic mice 1) in the 
presence of tamoxifen in double-transgenic mice that carried the reporter construct and 
expressed either NCreERT2 or ERT2CCre (Fig. 22 A, B); 2) in triple-transgenic mice that 
received no tamoxifen (Fig. 22 C). All these control experiments were performed and no RFP 
expression was detected (n ≥ 3 mice each; data, which consists of black images with no 
fluorescence to detect, not shown) showing that only one Cre part (NCreERT2 or 
ERT2CCre) is not enzymatically active and that both Cre parts cannot complement and form 
the active enzyme without the presence of tamoxifen. 
 
  
Fig. 22: Schematic representation of control experiments for the Split-CreERT2-mediated RFP-
expression in transgenic mice. A: In double-transgenic mice carrying the RFP reporter and 
expressing only NCreERT2 in GABAergic neurons no RFP fluorescence was detectable. B: Also no 
RFP expression was found in double-transgenic mice carrying the reporter and expressing only 
ERT2CCre in glycinergic neurons. C: In triple-transgenic mice containing the RFP reporter and 
expressing NCreERT2 as well as ERT2CCre in GgC neurons, respectively, no RFP fluorescence was 
detected without application of tamoxifen. 
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5.5.4 Fate-mapping of GABA and glycine cotransmitting neurons 
The quantification of GABAergic, glycinergic and GgC neurons in Cofluor mice at different 
ages showed a developmental shift from dual GABA/glycinergic to pure GABAergic or 
glycinergic transmission (5.4). In Cofluor mice it was not possible to analyse the fate of GgC 
neurons because the fluorescent proteins tdTomato (in GABAergic neurons) and EGFP (in 
glycinergic neurons) are only expressed in a time-period of GAD65 or GlyT2 promoter 
activity and fluorescence is gone when the promoter is silenced. The possibility to irreversibly 
stain GgC neurons at a specific time-point in development in transgenic mice allows the 
investigation of the fate of these neurons. Irreversible staining of GgC neurons with RFP was 
achieved in triple-transgenic COTRIND mice after application of the inducer tamoxifen at P1 
and P2. The identity of the labelled cells was analysed one day after the last tamoxifen 
application at the age of P3 as well as at the age of 2.5 month. Analysis of GgC neurons 
earlier than P3 was not possible since RFP-fluorescence was firstly detected at P3 after 
tamoxifen injections at P1/P2. For the analysis of cell fate immunohistochemical staining 
using antibodies raised against glycine and GAD65 (Fig. 23 A-C and Fig. 24 A-C) was 
performed in COTRIND mice followed by the quantification of cells expressing only RFP, 
RFP and glycine, RFP and GAD65 as well as RFP together with both, glycine and GAD65 
(Fig. 23 D and Fig. 24 D, all mean ± SD; n = 3 mice).  
In the PBC of COTRIND mice at the age of P3 66.9% (± 2.6%) of RFP-labelled neurons were 
double-positive for glycine and GAD65 immunoreaction whereas 12.4% (± 3.2%) were only 
positive for glycine and 10.2% (± 0.9%) only expressed GAD65. 10.5% (± 2%) of RFP-
positive neurons expressed no detectable levels of glycine and GAD65-protein (Fig. 23 D). 
These data show that many GgC neurons from P1/2 were still GgC neurons at P3 but 
differentiation to pure glycinergic and pure GABAergic neurons already started. In addition 
these results imply that the vast majority of RFP-labelled neurons are indeed GgC neurons 
since a high number of these neurons showed coexpression of glycine and GAD65. 
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Fig. 23: Fate-analysis of GgC neurons in COTRIND mice at the age of P3 after tamoxifen 
injection at P1 and P2. A: Tamoxifen was applied to COTRIND mice at the age of P1 and P2 to 
induce RFP expression for irreversible staining of GgC neurons. Mice were sacrificed at P3. B: RFP-
expressing cells (pink) show neurons that were GgC neurons at the age of P1/P2. At the age of P3 
immunohistochemical staining was performed with an antibody raised against glycine (green) to 
identify glycinergic neurons and an antibody raised against GAD65 (red) to detect GABAergic 
neurons. The yellow arrows highlight RFP-expressing neurons that show immunoreactivity against 
both, glycine and GAD65 whereas the green arrow shows a RFP-expressing neuron that is also 
glycine-positive. The red arrow marks a RFP-positive neuron that expresses GAD65 but not glycine. 
C, D: To exclude unspecific binding of the secondary antibodies negative controls lacking the primary 
antibody against glycine (C) and GAD65 (D) were performed in parallel and showed no cross-reaction 
of the secondary antibodies with the tissue. The scale bar represents 50 µm and applies to all panels. 
D: Quantification of cells that showed only RFP fluorescence (pink); RFP-positive cells expressing 
glycine in the absence of GAD65-immunoreactivity (green); RFP-expressing neurons that showed 
immunoreactivity against both glycine and GAD65 (yellow) as well as RFP-positive cells expressing 
GAD65 but lacking glycine (red).  
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Furthermore, the fate of GgC neurons from P1/2 was investigated 2.5 month later in adult 
COTRIND mice (Fig. 24 A-C). In comparison to mice at the age of 3 days 58.1% (± 2.0%) of 
RFP-labelled neurons were only positive for glycine, whereas 9.3% (± 4.6%) expressed only 
GAD65. 23.3% (± 3.6%) of RFP-expressing cells were double-positive for glycine and 
GAD65 immunoreaction and 9.3% (± 0.4%) were RFP-positive in the absence of detectable 
levels of glycine and GAD65-protein (Fig. 24 D). These data imply that most GgC neurons 
from P1/P2 develop to glycinergic neurons whereas a smaller proportion differentiates a 
GABAergic phenotype. One fourth of these neurons labelled at P1/P2 are still GgC neurons 
at the age of 2.5 mo.  
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In addition to the fate-mapping of GgC neurons the total cell number of RFP-labelled neurons 
was analysed in COTRIND mice at P 3 and 2.5 month after tamoxifen application at P1/P2 
This experiment was performed to determine the proportion of RFP-stained neurons that 
survived during development from P3 to 2.5 month. The cell density was related to the area 
of the entire coronal brainstem slices and in addition to the nearest located structure, the N. 
amb (as described in detail above for Cofluor mice, see 5.4). As expected the area of the 
slices (red bars) as well as the area of the N. amb. (blue bars) increases with the growth of 
the mouse brain from P3 to 2.5 month (Fig. 25 B) whereas the cell density decreases at the 
same time (Fig. 25 C). The estimated cell numbers of each analysed age related to the 
growth of the brainstem slices (Fig. 25 D, red bars) and the N. amb. (Fig. 25 D, blue bars) 
showed no significant differences compared to 2.5 month implying that the number of 
inhibitory neurons in the PBC which were labelled at P1/P2 by tamoxifen injection in 
COTRIND mice does not change substantially during development. 
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← Fig. 24: Fate-mapping of GgC neurons after 2.5 month. A: Tamoxifen was applied to COTRIND 
mice at the age of P1 and P2 to induce RFP expression for irreversible staining of GgC neurons. 2.5 
mo later these mice were sacrificed. B: RFP-expressing cells (pink) show neurons that were GgC 
neurons at the age of P1/P2. Investigation of the fate was performed 2.5 mo later by 
immunohistochemical staining with an antibody raised against glycine (green) and an antibody raised 
against GAD65 (red). The green arrow shows a RFP-expressing neuron that is also glycine-positive 
while the yellow arrow highlights a RFP-labelled neuron that shows immunoreactivity against both 
glycine and GAD65. The red arrow points a RFP-positive neuron that expresses GAD65 but not 
glycine. C, D: To exclude unspecific binding of the secondary antibodies negative controls lacking the 
primary antibodies against glycine (C) and GAD65 (D) were performed in parallel and showed no 
cross-reaction of the secondary antibodies with the tissue. The scale bar represents 50 µm and 
applies to all panels. D: Quantification of cells that showed only RFP fluorescence (pink); RFP-positive 
cells expressing glycine in the absence of GAD65-immunoreactivity (green); RFP-expressing neurons 
that showed immunoreactivity against both glycine and GAD65 (yellow) as well as RFP-positive cells 
expressing GAD65 but lacking glycine (red).  
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Fig. 25: No change in cell numbers of RFP-labelled neurons in the PBC of COTRIND mice that 
received tamoxifen at P1/P2 during development. A: Coronal brainstem slice of a COTRIND mouse 
(here at the age of 2.5 mo) that received tamoxifen applications at P1 and P2. The red line marks the 
area of the whole coronal brainstem slice; the blue line highlights the area of the N. amb. RFP-labelled 
neurons were quantified in 3 sections of the PBC (white line) for 3 slices per mouse and 3 mice per 
age (n = 3). The scale bar represents 1mm. B: The area of the coronal slices (red bars, left y-axis) as 
well as the N. amb. (blue bars, right y-axis) increases during development from P3 to 2.5 mo whereas 
the cell density of inhibitory neurons in the PBC decreases (C). The values of P3 were compared to 
2.5 mo. *p ≤ 0.001 vs. 2.5 mo. D: The estimated cell number calculated using the area of the whole 
coronal slices (red bars, left y-axis) or the area of the N. amb. (blue bars, right y- axis) shows no 
significant differences in mice at the age of P3 compared to 2.5 mo. 
 
 
In summary, the number of permanently RFP labelled neurons at P1/P2 in COTRIND mice 
remains constant between P3 and 2.5 month suggesting that GgC neurons from P1/P2 
survive during development. Though, a high percentage of GgC neurons from P1/P2 lose 
their dual-transmitting phenotype and differentiate to glycinergic neurons as well as in a 
minor part to GABAergic neurons.  
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6. Discussion 
Neurons of the PBC are responsible for the generation of the respiratory rhythm (Pierrefiche 
et al., 1998; Smith et al., 1991). However, the mechanism of rhythm generation is poorly 
understood. Inhibitory interneurons of the PBC play a crucial role in the generation and 
patterning of this rhythmic activity. Rhythm generation depends on synaptic interaction based 
on reciprocal inhibition of different neuron groups (Richter et al., 1979; Rybak et al., 2007). 
Inhibitory interneurons of the PBC use GABA or glycine for signal transmission. In recent 
years the influence of glycinergic transmission on the generation of the respiratory rhythm 
was thoroughly investigated and found to be essential for breathing (Büsselberg et al., 2001; 
Gomeza et al., 2003). Furthermore, a high proportion of glycinergic neurons were identified 
as inspiratory neurons (Winter et al., 2009). GABAergic interneurons in the cardiorespiratory 
system show a pacemaker phenotype and increase the activity of inspiratory neurons by the 
inhibition of post-inspiratory neurons (Frank and Mendelowitz, 2012). It is known that both 
transmitters, GABA and glycine, share the same vesicular transporter VIAAT (Burger et al., 
1991; Christensen et al., 1990, 1991) and a simultaneous release of GABA and glycine from 
the same vesicle was described for different regions of the brainstem (Kuo et al., 2009; Lu et 
al., 2008) and spinal cord (Ishibashi et al., 2013; Jonas et al., 1998). However, it has not 
been analysed so far whether GgC neurons also exist in the PBC and what role they play for 
respiratory rhythm generation.  
Aim of this work was the detection of GgC neurons in the PBC with different approaches and 
their developmental analysis in novel generated BAC-transgenic mice. In this chapter the 
methods used for the identification of GgC neurons and the transgenic mouse models 
including their intrinsic limitations as well as the results obtained from the developmental 
analysis of GgC neurons will be discussed. Finally, the functional significance of GABA and 
glycine cotransmission for respiratory rhythm generation within different stages of 
development is debated. 
 
6.1 GgC neurons exist in the PBC 
The observation of a simultaneous release of GABA and glycine in different regions of the 
mouse brain lead to the first hypothesis: GgC neurons also exist in the PBC. The detection of 
GgC neurons in the PBC was performed at mRNA level using scRT-PCR, by 
immunohistochemical staining against GABA in glycinergic neurons of TgN(GlyT2-EGFP) 
mice and by identifying combined GAD65- and GlyT2-positive neurons in novel generated 
transgenic Cofluor mice. All these different techniques lead to the same result and showed 
the presence of GgC neurons in the PBC of mice confirming the first hypothesis. 
However, some technical limitations of the methods used for the identification of GgC cells 
have to be taken into account. Single cell RT-PCR showed the existence of mRNAs for at 
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least one GABAergic neuronal marker (GAD65, GAD67, and/or GAT1) in nearly two-thirds of 
EGFP-positive neurons in GlyT2-EGFP mice (Fig. 8 C). As a control for the glycinergic 
phenotype of EGFP-expressing neurons coexpression of GlyT2 mRNA was analysed but 
detection failed in some EGFP-labelled cells. Different reasons might underlie this result: 1) 
some neurons express EGFP but aren’t glycinergic neurons. Such an ectopic expression 
may depend on the integration site of the transgene within the genome or the genetic 
background. However, the mouse-line TgN(GlyT2-EGFP) is immunohistochemically and 
physiologically well verified (Zeilhofer et al., 2005). In addition, immunohistochemical 
verification of GlyT2-EGFP mice using antibodies raised against GlyT2 and glycine showed 
high overlap of EGFP expression and antibody staining in the PBC (data not shown) also 
suggesting a very low rate – if at all – of ectopic EGFP expression. 2) GlyT2 mRNA level is 
very low in the cytoplasm, perhaps because of a direct transport of GlyT2 mRNA to synaptic 
terminals where GlyT2 protein is integrated into the membrane or because of a high stability 
of the GlyT2 protein. However, no localisation signal was found within the sequence of GlyT2 
(data not shown) nor such a localization of Glyt2 mRNA was so far described in the literature. 
Nevertheless, low cytosolic GlyT2 mRNA amounts potentially in combination with the onset 
of mRNA degradation shortly after harvesting of the cytosol may lead to the failed detection 
of GlyT2 mRNA in some EGFP-positive neurons. Additional, scPCR showed a heterogeneity 
of the expression pattern of GAD65, GAD67 and GAT1 (Fig. 8 B). It is described that both 
GAD isoforms as well as GAT1 are coexpressed in most neurons (Feldblum et al., 1993; 
Scimemi, 2014; Yasumi et al., 1997). GAT1 was always detected together with GAD65 or 
GAD67 whereas a coexpression of GAD65 and GAD67 mRNA was found in only few cells. 
Differences of the amount of GAD65 and GAD67 mRNA were described previously for 
various brain regions (Esclapez et al., 1993, 1994) and a very low concentration of mRNAs 
may lie underneath the limit of detection by using reverse transcription and PCR at a single 
cell level. Taking these limitations into account, at least half of the analysed neurons in the 
PBC expressed the mRNA suggestive for a dual GABA/glycinergic phenotype providing 
evidence that a high proportion of glycinergic neurons in the PBC also use GABA for signal 
transmission between the first and the tenth postnatal day. However, a cotransmission or 
rather a corelease of both transmitters cannot be investigated by using scRT-PCR or 
immunohistochemistry. To analyse whether these double-positive neurons really corelease 
GABA and glycine and how they contribute to the rhythm generation in the PBC a 
physiological characterisation has to be performed. Since the detection of GgC neurons in-
vivo or in acutely isolated brain slices is very challenging a novel transgenic mouse-line was 
established providing the identification of GgC neurons as well as GABAergic and glycinergic 
neurons by the expression of different fluorescent proteins. To achieve this goal two 
transgenic mouse-lines expressing different fluorescent proteins in GABAergic and in 
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glycinergic neurons had to be combined. Recently, a mouse-line expressing EGFP under 
control of the GlyT2 promoter was generated for the investigation of glycinergic neurons 
(Zeilhofer et al., 2005). GlyT2 is responsible for the re-uptake of glycine into pre-synaptic 
nerve terminals and its presence is described to be a reliable marker for glycinergic neurons 
(Poyatos et al., 1997). The expression of GAD65 and GAD67, the GABA-synthesizing 
enzymes, identifies GABAergic neurons. Two mouse-lines expressing EGFP under control of 
the GAD67 (Oliva et al., 2000; Tamamaki et al., 2003) or GAD65 promoter (López-Bendito et 
al., 2004) in GABAergic neurons are available. However, a simultaneous labelling of 
GABAergic and glycinergic neurons is not possible by combining two EGFP-expressing 
mouse-lines. To overcome this limitation a novel transgenic mouse-line expressing the red 
fluorescent protein tdTomato in GABAergic neurons under the control of the GAD65-
promoter was established by using BAC transgenesis. GAD65-tdTomato mice showed a 
stable and bright expression of the red fluorescent protein tdTomato exclusively in 
GABAergic neurons in all expected regions e.g. the olfactory bulb, striatum, cortex and 
brainstem (Fig. 10, Fig. 11; Besser et al., 2015). The observed distribution of tdTomato-
expressing cells is in accordance with results from previous studies investigating the 
distribution of GAD65 and GAD67 mRNA using in situ hybridization (Erlander et al., 1991; 
Esclapez et al., 1993, 1994; Feldblum et al., 1993). Furthermore, tdTomato-expressing cells 
were verified using immunohistochemical staining against the endogenous GAD65 protein 
(Fig. 12). 80% to 90% of GAD65-positive cells expressed tdTomato, indicating that a high 
proportion of GABAergic neurons are labelled by tdTomato fluorescence. Importantly, only 
very few cells showed the presence of tdTomato in the absence of GAD65 immunoreactivity 
(0.1% – 1.4%; Fig. 12 E), indicating that expression of tdTomato within a cell allows the 
identification as a GABAergic cell with a very low error rate (Besser et al., 2015).  
The expression of a fluorescent protein in the red range of the spectrum is unique among the 
existing transgenic mouse-lines labelling GABAergic neurons. Combining GAD65-tdTomato 
mice with GlyT2-EGFP mice (Fig. 13) allows for the first time the concurrent labelling of 
GABAergic neurons with red fluorescence and glycinergic neurons with green fluorescence 
in the double-transgenic mouse-line called Cofluor (Fig. 13 B). In addition to “red” GABAergic 
neurons and “green” glycinergic neurons a third neuron population was found in Cofluor mice 
at the age of ten days. These “yellow” neurons express tdTomato together with EGFP and 
were defined as GgC neurons (Fig. 13 B). Although a corelease of GABA and glycine from 
these cells is not shown directly in the frame of the present work, the simultaneous activity of 
both promoters, GAD65 and GlyT2 determining a dual GABAergic and glycinergic 
phenotype, provides strong evidence that these neurons are GgC neurons. Physiological 
characterisation of GgC neurons in Cofluor mice and their involvement in the generation of 
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the respiratory rhythm as well as related pathologies was beyond the scope of this thesis, but 
is now ongoing in collaboration. 
To summarize, Cofluor mice are a valuable tool to identify GgC as well as GABAergic and 
glycinergic neurons in living tissue preparations. These mice facilitate physiological 
investigation of inhibitory circuits within the PBC but also other brain regions and therefore 
contribute to the functional analysis of inhibition for respiratory rhythm generation as well as 
other neuronal networks. 
 
6.2 Developmental analysis of GgC neurons in the PBC 
In different regions of the brain, e.g. the auditory centre, GABAergic transmission switches to 
glycinergic transmission showing GABA and glycine cotransmission during this transition 
(Awatramani et al., 2005; Kotak et al., 1998; Nabekura et al., 2004). Based on these findings 
the second hypothesis was postulated: The number of GgC neurons in the PBC changes 
during development. 
To analyse a developmental change of inhibitory neurons in the PBC quantification of 
GABAergic, glycinergic and GgC neurons was performed in Cofluor mice (Fig. 14) and 
revealed a decrease of the number of GgC neurons from E15.5 to 2.5 mo whereas mainly 
the percentage of glycinergic but also the proportion of GABAergic neurons increased.  
These data are in line with previous observations of homozygous GlyT2-KO mice which were 
viable in the first postnatal week but died prematurely around the end of the second postnatal 
week after displaying a complex neuromotor phenotype characterized by spasticity, a rigid 
muscle tone and strong tremor. GlyT2-KO mice showed first signs of an increased muscle 
tone already at P8 (Gomeza et al., 2003). In Cofluor mice the percentage of GgC neurons is 
between 64% to 35% before birth and in the first postnatal week. In this time window a lack 
of glycinergic transmission due to the loss of GlyT2 in homozygous GlyT2-KO mice could 
therefore be compensated by the additional release of GABA from cotransmitting neurons in 
combination with pure GABAergic synapses (16-30%). At the end of the second postnatal 
week the number of glycinergic neurons increased strongly to 50% and the proportion of 
GgC neurons was only around 13%. All homozygous GlyT2-KO mice died until P14 probably 
due to the loss of more than 60% of glycinergic transmission (Gomeza et al., 2003). Other 
data were obtained from mice that had a genetic ablation of VIAAT exclusively in glycinergic 
neurons (Rahman et al., 2015). These mice were not viable at birth. Consistent with the 
knowledge that both, GABA and glycine use VIAAT for synaptic vesicle filling a loss of VIAAT 
function in glycinergic cells means also a loss of VIAAT in GgC neurons which would 
additional affect vesicle filling and transmission of GABA in these cells. Furthermore, this 
means also that all GABAergic cells which develop from GgC neurons lack VIAAT and 
therefore transmission. In that case GABA cannot compensate for the loss of glycinergic 
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transmission. As a high percentage of neurons showed GABA and glycine cotransmission 
before and at birth the results from conditional VIAAT-KO mice (Rahman et al., 2015) are 
well in line with the observed data of the number of GABAergic, glycinergic and GgC 
neurons. 
Taken together, the quantitative analysis of GgC neurons in Cofluor mice revealed a 
developmental switch from GABA and glycine cotransmission to pure GABAergic and pure 
glycinergic transmission and provides for the first time an explanation for the severe 
phenotypes of GlyT2-KO and conditional glycinergic neuron-specific VIAAT-KO mice. 
 
What happens to GgC neurons during development? Based on the results of the 
quantification the third hypothesis was postulated: GgC neurons of the PBC differentiate into 
pure GABAergic or glycinergic neurons. 
Addressing this hypothesis fate-mapping of GgC neurons was performed using the Cre-loxP-
mediated DNA recombination in transgenic mice. This approach is successfully applied for 
lineage-tracing and fate-mapping analysis in various regions of the brain (e.g. 
Beckervordersandforth et al., 2014; Gil-Sanz et al., 2015; Zinyk et al., 1998). Genetic 
targeting of GgC neurons requires the control of Cre expression by the combination of two 
promoters, the GAD65 and the GlyT2 promoter, necessitating the use of the Split-Cre 
system. The present work provides for the first time a transgenic mouse-line, named 
COTRIND, carrying the tamoxifen-inducible Split-CreERT2 system (for details see 1.5, 
Fig. 4) for the irreversible staining of exclusively GgC neurons at a defined time-point of 
induction. Once labelled, GgC neurons can be investigated later in development determining 
their fate. By applying tamoxifen in the first two postnatal days irreversible labelling of GgC 
neurons by RFP expression was achieved at the age of P1/P2 in COTRIND mice. At the age 
of P3 and 2.5 month these mice were analysed revealing many RFP-labelled neurons in the 
PBC showing that GgC neurons from P1/2 were detectable one day after tamoxifen 
injections and importantly still exist in adult mice (Fig. 21 B and C). Furthermore, the number 
of RFP-labelled neurons in the PBC remains constant between P3 and 2.5 month (Fig. 25) 
demonstrating that GgC neurons from P1/2 survive during development. In contrast, an early 
postnatal programmed cell death is described for other brain regions e.g. the cerebral cortex 
(Gould and McEwen, 1993; Kole et al., 2013; Nikolić et al., 2013; Yamaguchi and Miura, 
2015). 
Fate-mapping in COTRIND mice at the age of P3 using immunohistochemical staining of 
GgC neurons labelled irreversibly at P1/P2 revealed that two thirds of RFP-labelled neurons 
were GgC neurons whereas a small percentage of cells showed only marker for GABAergic 
or glycinergic neurons (Fig. 23). On the one hand, this finding confirms that RFP-positive 
cells are indeed GgC neurons. On the other hand, this result shows that differentiation of 
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GgC neurons to glycinergic and GABAergic neurons is already ongoing which is well in line 
with the results from the quantitative analysis of inhibitory neurons in the PBC of Cofluor 
mice (compare Fig. 14) showing a decrease of the number of GgC neurons between P1 and 
P4 whereas the number of GABAergic and glycinergic neurons increases. 
In contrast, fate-mapping of GgC neurons marked irreversibly at P1/P2 in COTRIND mice at 
the age of 2.5 months revealed that more than half of GgC neurons developed a glycinergic 
phenotype, whereas a minor part differentiated to pure GABAergic neurons or remained GgC 
neurons. This result fits very well to the results of the quantitative analysis in Cofluor mice: 
Comparing the cell number of glycinergic, GABAergic and GgC neurons at P1 and 2.5 month 
in Cofluor mice the percentage of glycinergic neurons rises by 32%, the number of 
GABAergic cells increases by 9% and the proportion of GgC neurons falls by 41% 
(Fig. 26 A). Assuming that no cell dies between P1 and 2.5 month and regarding all GgC 
neurons from P1 as 100% (in COTRIND mice all red labelled neurons from P1/P2 were also 
set 100%) GgC neurons would develop in 60% to glycinergic neurons, in 17% to GABAergic 
neurons and remain GgC neurons in 23% (Fig. 26 B) similar to COTRIND mice (Fig. 26 C). 
The fate analysis of GgC neurons in different transgenic mouse-lines revealed comparable 
results implying that RFP labelled GgC neurons in COTRIND mice are a representative 
proportion of all GgC neurons.  
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Fig. 26: Development of GABAergic, glycinergic and GgC neurons in Cofluor mice from P1 to 
2.5 mo in comparison to the fate-analysis in COTRIND mice. A: Comparison of the cell number of 
GABAergic (red), glycinergic (green) and GgC neurons (yellow) at the age of P1 and 2.5 mo reveals 
an increase of 32% for glycinergic neurons, an increase of 9% for GABAergic neurons and a decrease 
of 41% for GgC neurons. B: Assuming that no cell dies GgC neurons from P1 would develop in 60% to 
glycinergic neurons, in 17% to GABAergic neurons and stay GgC neurons in 23% which represents a 
similar result to the fate-mapping analysis in COTRIND mice (C, modified from Fehler! Verweisquelle 
konnte nicht gefunden werden.). 
 
 
Confirming hypotheses two and three these data demonstrate that a high percentage of 
inhibitory neurons in the PBC make use of the simultaneous release of GABA and glycine in 
the early postnatal days but change their phenotype during maturation and develop to mostly 
glycinergic neurons in adult mice.  
 
 
 
 
Discussion_________________________________________________________________ 
66 
 
Technical considerations 
The establishment of the triple-transgenic mouse-line COTRIND required the generation of 
two single-transgenic mouse-lines, TgN(GAD65-NCreERT2) and TgN(GlyT2-ERT2CCre). 
Both lines were verified for the expression of NCreERT2 in GABAergic neurons as well as 
ERT2CCre in glycinergic neurons, respectively. Expression of the Cre-parts was achieved 
only in subpopulations of GABAergic and glycinergic neurons (Fig. 18 and Fig. 20) 
amounting to 60% and 80%, respectively. For triple transgenic COTRIND mice this would 
mean that only about half of the GgC neurons will be labelled by RFP-expression after 
tamoxifen-induced recombination. This estimation is based on the assumption that a random 
population of GABAergic and glycinergic neurons is labelled in single transgenic mice 
resulting in 0.6 * 0.8 = 0.48 ≙ 48% of neurons expressing both Cre parts after crossbreeding. 
However, it remains speculative whether a random population is labelled or whether a 
selective subpopulation of GABAergic and glycinergic neurons – e.g. depending on specific 
transcription factors – express NCreERT2 or ERT2CCre. Nevertheless, these data show that 
– although not all GgC neurons can be marked with this system – all RFP labelled neurons 
can be addressed as GgC neurons because NCreERT2 as well as ERT2CCre were only 
found in GABAergic and glycinergic neurons, respectively (compare Fig. 18 D and Fig. 20 D). 
Furthermore, control experiments showed no leakage of the Split-CreERT2 system in 
COTRIND mice without induction of DNA-recombination by tamoxifen application (Fig. 22) or 
in transgenic mice expressing only a single Cre-part but with tamoxifen induction. These 
experiments show for the first time that the Split-CreERT2-mediated recombination is 
functional in transgenic mice. GgC neurons were reliably marked by RFP expression and can 
further be analysed to identify their fate during development. 
Fate-mapping of GgC neurons irreversibly labelled by RFP-expression at P1/P2 was 
performed using immunohistochemical staining against glycine and GAD65. This analysis 
revealed that a major part of GgC neurons differentiated to glycinergic cells and a minor 
percentage developed to GABAergic neurons whereas one fourth stayed GgC neurons (see 
above). However, for a small portion of RFP-positive neurons antibody labelling failed. 
Different reasons are possible for this result: 1) These neurons were no GgC neurons at 
P1/P2 but showed RFP fluorescence due to an ectopic expression of NCreERT2 and/or 
ERT2CCre. This is rather unlikely since TgN (GAD65-NCreERT2) and TgN (GlyT2-
ERT2CCre) were verified for the expression of both Cre parts exclusively in GABAergic and 
glycinergic neurons and also control experiments proofed the functionality of the 
SplitCreERT2 system in the mouse-line COTRIND. 2) The antibodies used for the fate-
mapping experiment were not able to bind to RFP-positive neurons in deeper layers of the 
brainstem slices due tissue depth penetration issues. Nevertheless, an unambiguous 
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antibody staining was observed for more than 90% of red-labelled neurons in COTRIND 
mice which therefore represent a useful tool to investigate the fate of GgC neurons. 
 
6.3 Functional significance of GABA and glycine cotransmission  
What is the reason for neurons to simultaneously release two inhibitory neurotransmitters 
and is the functional relevance of GABA and glycine cotransmission diverse in different 
developmental stages?  
In prenatal and neonatal mice, both GABA and glycine lead to depolarisation of postsynaptic 
neurons due to a high intracellular chloride concentration (Balakrishnan et al., 2003; Kakazu 
et al., 1999; Lu et al., 1999; Rivera et al., 1999; Vu et al., 2000). Especially GABA as the first 
neurotransmitter to become functional in the developing neuronal network provides most of 
the initial excitatory drive (Represa and Ben-Ari, 2005). It has been postulated that the 
excitatory actions of GABA are critical for the formation of synapses and synaptic plasticity 
(Cherubini et al., 1991). In the neocortex and hippocampus GABA dependent synapse 
formation was found between E15 and P0 (Hennou et al., 2002; Wang and Kriegstein, 2008). 
The high amount of GABA and glycine cotransmitting neurons in the PBC between E15.5 
and P1 (64% - 53%) might also be important for synaptogenesis of inhibitory as well as 
excitatory glutamatergic pathways of the respiratory centre. Furthermore, the corelease of 
GABA in addition to glycine could lead to an increased calcium concentration in immature 
neurons due to a greater depolarisation which causes a greater calcium influx. Thereby 
GABA shows a longer-duration response (Nabekura et al., 2004; Smith et al., 2000) and 
therefore produces a more prolonged depolarisation than glycine, which further increases the 
calcium influx. This GABA induced membrane depolarisation in immature neurons is crucial 
for neuronal maturation (Ganguly et al., 2001; Gao and van den Pol, 2001; Lauder et al., 
1998). In addition, GABA induced calcium influx might be important for the insertion of 
glycine receptors into the synaptic membrane since the aggregation of glycine receptors by 
its anchoring protein gephyrin is promoted by calcium influx through channels in the 
postsynaptic membrane (Kirsch and Betz, 1998). This observation may also play a role in the 
developing PBC and the high amount of GABA and glycine cotransmission before birth might 
trigger glycinergic transmission which was found to increase from P1 to 2.5 month of age in 
this study (compare Fig. 14). Another function of GABA and glycine cotransmission in pre- 
and neonatal mice might be the activation of metabotropic GABAB receptors which may not 
be possible at pure glycinergic synapses. GABAB receptors are known to modulate the 
activity of voltage-dependent calcium channels (Karls and Mynlieff, 2015; Park et al., 2010) 
which may lead again to increased calcium concentration in the neurons (Karls and Mynlieff, 
2015) with the hypothesized consequences for the PBC (see above). Furthermore, during 
the first postnatal week GABA is responsible for the switch of the depolarizing GABA and 
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glycine response to hyperpolarizing responses (Ganguly et al., 2001) which concerns not 
only the PBC but also other brain regions with inhibitory transmission mediated by GABA and 
glycine. To summarize, the corelease of GABA and glycine in a high percentage of PBC 
neurons in pre- and neonatal mice (about 64%) remains to be shown directly by 
electrophysiology but might be important for the organisation and maturation of the neuronal 
network as well as the formation and tightening of synapses. The high amount of GABA 
seems to play a crucial role not only in the PBC but also in other regions of the brain since 
the (co-) release of GABA leads to increased intracellular calcium levels that are important 
for neuronal maturation, the development of glycinergic pathways as well as the 
hyperpolarizing action of GABA and glycine.  
During the first two postnatal weeks the functional organization of inhibitory synaptic 
mechanisms develops within the respiratory network (Paton and Richter, 1995). The 
generation of the respiratory rhythm undergoes a developmental change from a 'pacemaker' 
driven circuit at the neonatal stage to a network requiring postsynaptic inhibition in the 
mature brain (Hayashi and Lipski, 1992). Several physiological and molecular alterations are 
described in literature during this period: There is a developmental change in the molecular 
subunit structure of the glycine receptor (Becker et al., 1988; Malosio et al., 1991) which is 
known to accelerate the kinetics of the evoked chloride current (Akagi and Miledi, 1988; 
Takahashi et al., 1992) and therefore increases the efficacy of glycine as a powerful 
inhibitory neurotransmitter. In addition, the respiratory cycle changes from a two-phase to a 
three-phase oscillator including the postinspiratory phase which is suggested to permit a 
more precise and versatile reflex adjustment of ventilation. The first two postnatal weeks 
seem to play a crucial role in the reorganisation and stabilisation of the respiratory network 
(Paton and Richter, 1995). Within exactly this time-window, the strong decrease of the 
number of GgC neurons as well as most of the increase of the number of glycinergic neurons 
were found in this study confirming former observations that glycinergic inhibition becomes 
more present and effective after this transitional state (Akagi and Miledi, 1988; Becker et al., 
1988; Malosio et al., 1991; Paton and Richter, 1995; Takahashi et al., 1992). Nevertheless, 
molecular and physiological changes within this period remain to be further investigated to 
clarify developmental changes of respiratory rhythm generation and its functional relevance. 
In adult mice, cotransmission of GABA and glycine was present in about 13% of inhibitory 
neurons of the PBC. GABAergic and glycinergic IPSCs show different kinetics which can 
result in a precise regulation of the time course of the postsynaptic conductance by the 
differential filling of synaptic vesicles (Jonas et al., 1998). GABA acts as a weak agonist on 
postsynaptic glycine receptors accelerating glycinergic transmission and leading to a 
temporally more precise inhibition (Lu et al., 2008a). In addition, GABA can activate 
presynaptic GABAB receptors to reduce transmitter release at glycinergic synapses and 
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therefore lead to a feed-back regulation of transmitter release (Lim et al., 2000). In summary, 
in the mature PBC cotransmission of GABA and glycine might be responsible for a fine-
tuning of the transmitted signal whereas pure glycine-mediated inhibition is known to play a 
major role in off-switch mechanisms resulting in the transition of different phases of the 
respiratory cycle in the mature mammal (Ballantyne and Richter, 1984; Champagnat et al., 
1982; Haji et al., 1990, 1992; Hayashi and Lipski, 1992; Klages et al., 1993).  
It remains to be investigated whether the described mechanisms provoked by cotransmission 
of GABA and glycine in early and later development play a role for the maturation and 
function of the respiratory circuit. The newly generated transgenic mouse-lines Cofluor and 
COTRIND will facilitate identification and manipulation of GgC neurons in living brainstem 
preparations and therefore present valuable tools for the physiological analysis of this 
interesting neuron population. 
 
 
6.5 General conclusions 
The results of this work revealed that inhibition in the PBC is not only mediated by GABA or 
glycine but also by neurons cotransmitting both transmitters. The number of GgC neurons 
decreases during the first two postnatal weeks while mainly the numbers of glycinergic but 
also GABAergic neurons increase. Furthermore, most of the GgC neurons from P1/P2 
survived during development and differentiated into a mostly glycinergic as well as to a minor 
percentage a GABAergic phenotype. All three hypotheses addressed here were therefore 
confirmed by the results obtained from this study.  
In addition, the novel mouse-lines Cofluor and COTRIND generated in this study extend the 
tool box of transgenic mice for the investigation of inhibitory neurons. They provide for the 
first time the possibility to identify GgC neurons in vivo as well as in living brainstem 
preparations and will contribute to the elucidation of the physiological role of these neurons in 
the PBC but also other regions of the brain. Finally, the inducible Split-CreERT2 system was 
for the first time established in transgenic COTRIND mice and found to be functional in vivo 
without leakage. 
 
 
6.6 Outlook 
The present work provides novel transgenic mice for the physiological and developmental 
investigation of GgC neurons in the respiratory centre. The contribution of GgC neurons to 
the generation of the respiratory rhythm as well as the interplay of GABAergic, glycinergic 
and GgC neurons will be analysed in Cofluor mice allowing an easy identification of these 
three neuron types in vivo and in living slice preparations. Fate-mapping analysis of GgC 
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neurons will be continued by applying tamoxifen at different time-points in development (e.g. 
also before birth) to gain more information about the maturation of the respiratory network. In 
addition, the further characterisation of GgC neurons will comprise genetic targeting of these 
cells by using the Split-CreERT2-mediated DNA recombination in COTRIND mice in 
combination with different mouse lines with LoxP-flanked alleles for conditional genetic 
modification. One example is the mouse-line VIAATfl/fl which carries loxP-flanked VIAAT 
alleles (Rahman et al., 2015). Crossbreeding COTRIND mice to VIAATfl/fl mice will result in 
an ablation of VIAAT function after tamoxifen application exclusively in GgC neurons. 
Consequently, vesicle filling with GABA and glycine will be abolished in GgC neurons at a 
defined time-point in development resulting in a loss of synaptic transmission specifically of 
GgC neurons at a defined developmental stage. Therefore, this conditional, GgC neuron 
specific knock-out mouse will be a useful tool to investigate the function of GgC neurons in 
the PBC and their contribution to respiratory rhythm generation. In addition, it will also 
provide information of the function of GgC neurons in other regions of the brain that show 
GABA and glycine cotransmission. 
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7. Summary 
Breathing is fundamental for life and requires a fine-tuned activity of different groups of 
neurons resulting in alternating contractions of respiratory muscles. Nevertheless, the 
mechanism of rhythm generation is not yet fully understood. A brain region crucial for the 
generation of the respiratory rhythm is the Pre-Bötzinger-Complex (PBC), a part of the 
Ventral Respiratory Group in the lateral medulla oblongata (Feldman and Del Negro, 2006; 
Richter and Spyer, 2001; Richter, 1996). Many neurons of this respiratory network show 
pacemaker activity generating trains of rhythmic action potentials (Butera et al., 1999; Del 
Negro et al., 2002; Johnson et al., 1994; Paton et al., 2006). These intrinsic mechanisms are 
regulated by inhibitory interneurons that use GABA or glycine as neurotransmitter 
(Brockhaus and Ballanyi, 1998; Feldman and Del Negro, 2006; Onimaru et al., 1990; 
Pierrefiche et al., 1998; Richter and Spyer, 2001; Richter, 1996; Winter et al., 2009) 
GABAergic interneurons in the respiratory system show a pacemaker phenotype and are 
supposed to increase the activity of neurons responsible for inspiration by inhibiting post-
inspiratory neurons (Frank and Mendelowitz, 2012). Furthermore, the contribution of 
glycinergic neurons to the respiratory rhythm generation is crucial for breathing. (Büsselberg 
et al., 2001; Gomeza et al., 2003; Winter et al., 2009). GlyT2-KO mice that lack glycinergic 
transmission are viable in the first postnatal week but die during the second postnatal week 
showing a phenotype similar to hyperekplexia. This raises the question whether there is a 
compensatory mechanism for loss of glycinergic transmission in the first days after birth 
which could be for instance cotransmission of a second inhibitory transmitter like GABA. Both 
transmitters, GABA and glycine, share the same vesicular transporter (vesicular inhibitory 
amino acid transporter (VIAAT); (Burger et al., 1991; Christensen et al., 1990, 1991). 
Consistently, mice with a deletion of VIAAT in glycinergic neurons (Rahman et al., 2015) are 
not viable and die shortly after birth. Hypothesizing that some neurons of the PBC corelease 
both transmitters a loss of VIAAT function in glycinergic neurons would also affect 
GABAergic transmission. These findings are first indications for a dual GABAergic and 
glycinergic transmission in the respiratory centre, especially in early development. A 
simultaneous release of GABA and glycine from the same vesicle was described for different 
regions of the brainstem (Kuo et al., 2009; Lu et al., 2008) and spinal cord (Ishibashi et al., 
2013; Jonas et al., 1998). However, detection as well as functional and morphological 
analysis of GABA and glycine cotransmitting (GgC) neurons is challenging because of 
lacking possibilities for visualisation and genetic targeting in vivo or in living tissue 
preparations.  
The present work investigated the existence, the development and the fate of GgC neurons 
in the PBC of mice. Two novel transgenic mouse-lines were generated allowing for the 
visualisation as well as the temporally controlled permanent genetic labelling of GgC neurons 
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in vivo and acute slice preparations facilitating the physiological investigation and fate-
mapping of these neurons.  
The first part of this research was dedicated to test the hypothesis that GgC neurons exist in 
the PBC of mice. The presence of GgC neurons was analysed using several approaches. 
Single-cell RT-PCR performed with mice at an age between P1 and P10 revealed that a high 
percentage of glycinergic neurons in TgN(GlyT2-EGFP) mice (Zeilhofer et al., 2005) also 
contained mRNA suggestive for an additional GABAergic phenotype providing evidence for 
the presence of GgC neurons in the PBC. This result was confirmed by 
immunohistochemical staining with an antibody raised against the transmitter GABA. Many 
glycinergic neurons of 10-day-old GlyT2-EGFP mice showed immunoreactivity against GABA 
suggesting that these neurons cotransmit GABA and glycine. To further substantiate these 
findings a novel transgenic mouse-line was established allowing for the visualisation of GgC 
neurons in vivo and living slice preparations without additional staining procedures. In the 
Cofluor mouse line, GABAergic neurons express the red fluorescent protein tdTomato, 
glycinergic neurons express the green fluorescent protein EGFP, while GgC neurons show 
expression of both fluorescent proteins. Taking advantage of this new transgenic mouse line, 
the presence of GgC neurons in the PBC was confirmed. Taken together, these analyses 
provide strong evidence that indeed GgC neurons exist within the PBC of mice. 
Electrophysiological characterisation of GgC neurons and their involvement in the generation 
of the respiratory rhythm as well as related pathologies is now ongoing in collaboration.  
The second part of the dissertation addressed the development and the fate of GgC neurons. 
Based on the severe phenotype of mice lacking GlyT2 (described above) the second 
hypothesis was postulated, claiming that the number of GgC neurons changes during 
development. To test this hypothesis, the distribution of GgC neurons as well as GABAergic 
and glycinergic neurons in the PBC was analysed in different developmental stages before 
and after birth to characterize the amount of cotransmission at different ages. It was found 
that the percentage of GgC neurons was high at the embryonal days E15.5 and E17.5 but 
decreased continuously from P1 to P14 whereas the proportion of glycinergic and 
GABAergic neurons increased. This switch from GgC to glycinergic inhibitory neurons 
coincides with the time point when GlyT2-KO mice die (see above; Gomeza et al., 2003), 
suggesting that indeed GABAergic transmission can compensate for loss of inhibitory 
transmission in those mice as long as inhibitory neurons have GgC properties.  
As the total number of all inhibitory neurons remained constant between P1 and 2.5 month it 
was further hypothesized that GgC neurons differentiate to glycinergic and GABAergic 
neurons. Analysis of the fate of GgC neurons was performed using the novel established 
transgenic mouse-line COTRIND carrying the inducible Split-CreERT2 system for the 
irreversible genetic labelling of GgC neurons with a red fluorescent reporter protein (RFP) at 
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the time-point of tamoxifen application. Permanent labelling of GgC neurons at P1/P2 and 
quantification of labelled neurons at P3 and after 2.5 month revealed no significant 
differences in the total cell number suggesting that GgC neurons survive from P3 to 2.5 
month of age. Based on immunohistochemistry, the fate of GgC neurons from P1/P2 was 
tracked 2.5 month later revealing that a high percentage of GgC neurons differentiated to 
glycinergic neurons whereas a minor proportion developed to GABAergic neurons or 
remained GgC neurons.  
Taken together, the results of the present work provide strong evidence that inhibition in the 
PBC is not only mediated by GABA or glycine but also by neurons cotransmitting both 
transmitters. The proportion of GgC neurons decreased during the first two postnatal weeks 
while mainly the percentage of glycinergic but also GABAergic neurons increased. 
Furthermore, most of the GgC neurons from P1/P2 survived during development and 
differentiated to glycinergic as well as to a minor percentage to GABAergic neurons. The 
novel mouse lines Cofluor and COTRIND generated in this study extend the tool box of 
transgenic mice for the investigation of inhibitory neurons. They provide for the first time the 
possibility to identify GgC neurons in vivo and in living brainstem preparations as well as to 
genetically target this cell population and will further contribute to the elucidation of the 
physiological role of these neurons in the PBC but also other regions of the brain.  
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8. Zusammenfassung 
Die Atmung erfordert eine andauernde, rhythmisch wechselnde Aktivität verschiedener 
Neuronengruppen, um die oszillierende Kontraktion der Atemmuskulatur zu gewährleisten. 
Viele Aspekte der Generierung des Atemrhythmus sind jedoch noch nicht gut verstanden. 
Eine für die Rhythmusgenerierung bedeutende Hirnregion ist der Prä-Bötzinger Komplex 
(PBC), welcher sich in der lateralen Medulla oblongata befindet und Teil der ventralen 
respiratorischen Gruppe ist (Feldman and Del Negro, 2006; Richter and Spyer, 2001; 
Richter, 1996). Viele Neurone dieses respiratorischen Netzwerks besitzen 
Schrittmacheraktivität und können rhythmische Aktionspotentialsalven generieren (Butera et 
al., 1999; Del Negro et al., 2002; Johnson et al., 1994; Paton et al., 2006). Diese 
intrinsischen Mechanismen werden durch hemmende Interneurone reguliert, welche GABA 
oder Glyzin als Neurotransmitter verwenden (Brockhaus and Ballanyi, 1998; Feldman and 
Del Negro, 2006; Onimaru et al., 1990; Pierrefiche et al., 1998; Richter and Spyer, 2001; 
Richter D., 1996; Winter et al., 2009). GABAerge Interneurone mit 
Schrittmachereigenschaften erhöhen die Aktivität von Nervenzellen, welche für die 
Inspiration verantwortlich sind (Frank and Mendelowitz, 2012). Glyzinerge Neurone sind von 
entscheidender Bedeutung für die Aufrechterhaltung des Atemrhythmus (Büsselberg et al., 
2001; Gomeza et al., 2003; Winter et al., 2009). GlyT2-„knock out“-Mäuse, denen die 
glyzinerge Signalübertragung fehlt, sind in der ersten Woche nach der Geburt lebensfähig. 
Sie sterben jedoch in der zweiten Lebenswoche an einem Hyperekplexie-ähnlichem 
Krankheitsbild. Dies wirft die Frage auf, ob der Verlust der inhibitorischen, glyzinergen 
Informationsübertragung in den ersten Tagen nach der Geburt kompensiert werden kann; 
beispielsweise durch die Cotransmission eines zweiten inhibitorischen Transmitters wie 
GABA. Sowohl GABA als auch Glyzin, werden durch den gleichen vesikulären Transporter 
(„vesicular inhibitory aminoacid transporter“; VIAAT) in synaptische Vesikel transportiert 
(Burger et al., 1991; Christensen et al., 1990, 1991). Mäuse mit einer genetischen Deletion 
dieses Transporters spezifisch in glyzinergen Neuronen sterben kurz nach der Geburt 
(Rahman et al., 2015). Der Verlust von VIAAT in glyzinergen Neuronen könnte sich jedoch 
auch auf die GABAerge Informationsübertragung auswirken, wenn Neuronen des PBC beide 
Neurotransmitter zusammen freisetzen. Daher geben diese Beobachtungen erste Hinweise 
für eine Cotransmission von GABA und Glyzin im Atemzentrum in der frühen 
Entwicklungsphase von Mäusen. Während die gleichzeitige Freisetzung von GABA und 
Glyzin aus dem gleichen Vesikel in anderen Bereiche des Hirnstamms (Kuo et al., 2009; Lu 
et al., 2008) und des Rückenmarks (Ishibashi et al., 2013; Jonas et al., 1998) gezeigt 
wurden, liegen dazu keine Daten aus dem Atemzentrum vor. Jedoch sind sowohl der 
Nachweis als auch die funktionelle und morphologische Analyse von GABA und Glyzin 
cotransmittierenden (GGC) Neuronen aufgrund fehlender Möglichkeiten zur gezielten 
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genetischen Modifikation sowie der Visualisierung in vivo oder in akuten Gewebeschnitten 
schwierig. 
In der vorliegenden Arbeit wurden die Existenz, die Entwicklung und das Schicksal der GGC 
Neurone im PBC von Mäusen untersucht. Dazu wurden zwei neue transgene Mauslinien 
generiert, die es ermöglichen, GGC Neurone in vivo und in akuten Schnittpräparaten zu 
identifizieren als auch irreversibel zu einem bestimmten Zeitpunkt in vivo zu markieren. 
Beide Mauslinien erleichtern damit die physiologische Untersuchung und die Analyse des 
Schicksals der GGC Neurone.  
Im ersten Teil dieser Arbeit sollte folgende Hypothese untersucht werden: „GGC Neurone 
kommen im PBC von Mäusen vor“. Mehrere Techniken wurden zur Identifikation der GGC 
Neuronen herangezogen. Mittels Einzelzell-RT-PCR wurde gezeigt, dass ein hoher 
Prozentsatz an glyzinergen Neuronen in einen bis zehn Tagen alten TgN(GlyT2-EGFP)-
Mäusen (Zeilhofer et al., 2005) auch mRNA enthält, die charakteristisch für GABAerge 
Neurone ist. Das Ergebnis wurde mithilfe immunhistochemischer Färbungen unter 
Verwendung eines Antikörpers gegen den Neurotransmitter GABA bestätigt. Viele glyzinerge 
Neurone in GlyT2-EGFP-Mäusen im Alter von 10 Tagen zeigten Immunreaktivität gegen 
GABA. Schließlich wurde eine neue transgene Mauslinie erzeugt, die eine Identifikation von 
GGC Neuronen in vivo und akuten Schnittpräparaten ohne zusätzliche Färbeverfahren 
erlaubt. In der Mauslinie Cofluor exprimieren GABAerge Neurone das rot fluoreszierende 
Protein tdTomato, glycinerge Neurone das grün fluoreszierende Protein EGFP und GGC 
Neurone weisen die Expression beider Fluoreszenzproteine auf. Mithilfe dieser transgenen 
Mauslinie konnte die Existenz von GGC Neuronen im PBC ebenfalls bestätigt werden. 
Zusammenfassend zeigen diese Untersuchungen, dass tatsächlich GGC Neuronen im PBC 
von Mäusen existieren. Die elektrophysiologische Charakterisierung der GGC Neurone und 
ihre Beteiligung an der Generierung des Atemrhythmus als auch assoziierten Krankheiten 
werden derzeit in weiterführender Kooperation analysiert. 
Der zweite Teil dieser Arbeit befasst sich mit der Entwicklung und dem Schicksal der GGC 
Neurone. Basierend auf dem oben beschriebenen Phänotyp der GlyT2-KO-Mäuse wurde die 
zweite Hypothese formuliert „Die Anzahl der GGC Neurone ändert sich während der 
Entwicklung.“ Um diese Hypothese zu testen, wurde die Anzahl der GGC Neurone sowie der 
GABAergen und glyzinergen Neurone im PBC in verschiedenen Entwicklungsstadien vor 
und nach der Geburt untersucht und der Anteil an Cotransmission in verschiedenen 
Altersstufen charakterisiert. Es wurde festgestellt, dass die Anzahl der GGC Neurone vor der 
Geburt an den embryonalen Tagen E15.5 und E17.5 hoch war, sich jedoch nach der Geburt 
kontinuierlich bis zum Alter von P14 verringerte Der Anteil der glyzinergen und GABAergen 
Neuronen erhöhte sich dagegen im gleichen Zeitraum. Dies korreliert sehr gut mit dem 
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Zeitpunkt, an dem Mäuse mit einem Verlust des GlyT2-Gens sterben (Gomeza et al., 2003), 
und unterstützt die These, dass GABA-vermittelte Inhibition in frühen Entwicklungsstadien 
bis zum Alter von maximal 2 Wochen einen Verlust glyzinerger Transmission kompensieren 
kann. 
Da die Gesamtzahl aller hemmenden Neurone im Alter zwischen P1 und 2,5 Monaten 
konstant blieb, wurde weiterhin untersucht, ob sich GGC Neurone zu glyzinergen und/oder 
GABAergen Neuronen differenzieren. Die Analyse dieser Hypothese erfolgte mithilfe der neu 
etablierten transgenen Mauslinie COTRIND, welche das Tamoxifen-induzierbare Split-
CreERT2 System in GGC Neuronen exprimiert. In COTRIND-Mäusen können GGC Neurone 
zum Zeitpunkt der Tamoxifenapplikation irreversibel mit dem rot fluoreszierenden 
Reporterprotein (RFP) markiert werden, um anschließend deren Schicksal in einem späteren 
Entwicklungsstadium zu untersuchen. In der vorliegenden Dissertation wurden GGC 
Neurone irreversibel im Alter von P1 / P2 markiert und zunächst deren Anzahl im Alter von 
P3 und 2,5 Monaten verglichen. Diese Untersuchung ergab keine signifikanten Unterschiede 
in der Gesamtzahl der markierten GGC Neurone in den analysierten Altersstufen, was darauf 
hindeutet, dass GGC Neurone im Zeitraum zwischen P3 und 2,5 Monaten überlebten. 
Mithilfe immunhistochemischer Färbungen wurde weiterhin die Eigenschaften der an P1 / P2 
markierten GGC Neuronen 2,5 Monate später analysiert. Dabei stellte sich heraus, dass sich 
eine große Anzahl an GGC Neuronen zu glycinergen Neuronen differenzierte während sich 
ein kleinerer Anteil zu GABAergen Neuronen entwickelte. 
Zusammenfassend zeigen die Ergebnisse der vorliegenden Arbeit, dass neuronale 
Hemmung im PBC nicht nur von GABAergen oder glyzinergen Neuronen vermittelt wird, 
sondern auch von Neuronen, welche beide Transmitter gleichzeitig freisetzen. Der Anteil der 
GGC Neuronen sinkt drastisch während der ersten zwei Lebenswochen, während vor allem 
der Prozentsatz an glyzinergen, aber auch GABAergen Neuronen steigt. Darüber hinaus 
konnte gezeigt werden, dass die meisten GGC Neurone vom frühen Entwicklungsstadium 
P1 / P2 auch noch im Alter von 2,5 Monaten existierten und sich zu vorranging glycinergen 
aber auch GABAergen Neuronen differenzierten. Die neuen Mauslinien Cofluor und 
COTRIND bieten erstmals die Möglichkeit, GGC Neurone in vivo und in lebenden 
Gewebeschnitten zu identifizieren sowie diese Zellpopulation genetisch zu modifizieren. 
Damit trägt diese Dissertation grundsätzlich zur Aufklärung der physiologischen Rolle der 
GGC Neurone nicht nur im PBC, sondern auch weiterer Hirnregionen bei.  
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10. Abbreviations 
 
amp  ampicillin 
AP  Alkaline Phosphatase 
as  antisense 
BAC  Bacterial Artificial Chromosome 
bp  base pair 
cam   chloramphenicol 
cDNA  complementary deoxyribonucleic acid 
ChAT  Choline Acetyltransferase 
CR  chemoreceptors 
Cre   Cre-DNA recombinase (causes recombination) 
CreERT2  tamoxifen inducible variation of Cre-DNA recombinase 
DAPI   4’,6-diamidino-2-phenylindole 
DNA  deoxyribonucleic acid 
dNTP   deoxynucleoside triphosphate 
DRG  Dorsal Respiratory Group 
EGFP  Enhanced Green Fluorescent Protein 
Ex  exon 
GABA  γ-aminobutric acid 
GAD  glutamate decarboxylase 
GAT  GABA transporter 
GgC  GABA and glycine cotransmitting 
GlyT2  glycine transporter type 2 
HA  homology arm 
HPSF  high purity salt free 
hsp  heat shock protein 
kana  kanamycin 
loxP   locus of crossover (x) from bacteriophage P1 
LSM   confocal laser scanning microscope 
M  DNA size marker 
mo  month 
mRNA  messenger ribonucleic acid 
N. amb. Nucleus ambiguus 
neo  neomycin 
NTS  Nucleus tractus solitarii 
PBC  Pre-Bötzinger Complex 
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PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
PFA   paraformaldehyde 
RFP  Red Fluorescent Protein 
RNA   ribonucleic acid 
RT   room temperature 
RT-PCR reverse transcription polymerase chain reaction 
s  sense 
sc  single-cell 
tet  tetracyclin 
tg  transgenic 
VIAAT  vesicular inhibitory amino acid transporter 
VRG  Ventral Respiratory Group 
wt  wild type 
β-Gal  β-Galactosidase 
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